ASHUMGulf news and Dubai stocks, live

Financial Statements for the period from January 2025 to December 2025 CHAE

Lunate S&P UAE UCITS ETF - Share A - ACCUMLATING 109 pages

Document109 pages, text from the file; its scanned pages read by AshumOpen DFM’s file

Page 1

30 /04/ 2026

Mr. Hamed Ahmed Ali

CEO

Dubai Financial Market (DFM)

Dubai, United Arab Emirates

Greetings,

Subject: Notification by Lunate Capital Limited on behalf of Chimera UCITS ICAV

Please be informed that Lunate Capital Limited received the enclosed Annual Report and Audited Financial Statements from Chimera UCITS ICAV for the Period 1st of January 2025 to 31st December 2025.

Sincerely,

Sherif SalemHead of Public Markets

٢٠٢٦ / ٠٤ / ٣٠

السيد / حامد أحمد علي المحترم

الرئيس التنفيذي

سوق دبي المالي (DFM)

دبي، دولة الإمارات العربية المتحدة

تحية طيبة وبعد،

الموضوع: اخطار من شركة لونيت كابيتال ليمتد عن شيميرا يوسيتس ايكاف

نود اعلامكم بأن شركة لونيت كابيتال ليمتد استلمت التقرير السنوي و البيانات المالية المدققة من شيميرا يوسيتس ايكاف للفترة من ١ يناير ٢٠٢٥ إلى ٣٠ ديسمبر ٢٠٢٥ .

وتفضلوا بقبول وافر الاحترام،

شريف سالممدير إدارة الأسواق المالية

مرفق التقرير السنوي و البيانات من شيميرا يوسيتس ايكاف

Attached: Chimera UCITS ICAV Annual Report and Audited Financial Statements

LUNATE CAPITAL LIMITED12TH FLOOR, ALMARYAH TOWER,ABU DHABI,UNITED ARAB EMIRATESLUNATE.COM

Lunate Capital Limited is duly licensed and regulated by the ADGM Financial Services Regulatory Authority

Page 2

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025ICAV Registration Number: C188915

Page 3

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025Contents PageDirectors and Other Information 2Directors’ Report 3Report from the Depositary to the Shareholders 7Investment Manager’s Report 8Independent Auditor’s Report 20Statement of Financial Position 28Statement of Comprehensive Income 31

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares 34

Statement of Cash Flows 37Notes to the Audited Financial Statements 41Schedule of Investments 78Statement of Portfolio Changes (Unaudited) 91Appendix I: UCITS V Remuneration Policy (Unaudited) 105

Appendix II: Securities Financing Transactions Regulation (“SFTR”) Disclosures (Unaudited) 106

Appendix III: Sustainable Finance Disclosure Regulation (“SFDR”) Disclosures (Unaudited) 107

Page 4

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 2

Directors and Other InformationDirectors of the ICAVFeargal Dempsey (Irish)1Seif Fikry (Egyptian)2Jason Loveless (British)2Syl O’Byrne (Irish)1Sherif Salem (Egyptian)2Manager

FundRock Management Company S.A.

5, HeienhaffL-1736 SenningerbergGrand Duchy of Luxembourg

Investment Manager and Global Distributor Lunate Capital Limited

Unit 1, Floor 12, Al Maryah TowerAbu Dhabi Global Market SquareAl Maryah IslandAbu DhabiUnited Arab EmiratesDepositary*Effective from 3 June 2025

The Bank of New York Mellon SA/NV, Dublin Branch The Shipping Office

20-26 Sir John Rogerson's Quay Grand Canal Dock

Dublin 2D02 Y049IrelandUp to 2 June 2025

The Bank of New York Mellon SA/NV, Dublin Branch Riverside II

Sir John Rogerson’s QuayGrand Canal DockDublin 2Ireland

Administrator, Registrar and Transfer Agent* Effective from 3 June 2025

BNY Mellon Fund Services (Ireland) Designated Activity Company

The Shipping Office

20-26 Sir John Rogerson's Quay Grand Canal Dock

Dublin 2D02 Y049IrelandUp to 2 June 2025

BNY Mellon Fund Services (Ireland) Designated Activity Company

One Dockland CentralGuild Street

International Financial Services Centre Dublin 1

IrelandRegistered Office of the ICAVArthur Cox BuildingTen Earlsfort TerraceDublin 2D02 T380IrelandSecretaryBradwell LimitedTen Earlsfort TerraceDublin 2D02 T380IrelandIndependent AuditorsDeloitte Ireland LLP

Chartered Accountants and Statutory Auditors 29 Earlsfort Terrace

Dublin 2D02 AY28IrelandIrish Legal AdvisersArthur CoxTen Earlsfort TerraceDublin 2D02 T380IrelandInternational Legal AdvisersNorton Rose Eulbright4th FloorGate Precinct Building 3

Dubai International Financial Centre United Arab Emirates

* Please refer to Note 21 of the financial statements.

1 Independent and Non-executive Director.

2 Non-executive Director.

Page 5

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025

3Directors’ Report

The Board of Directors (the “Directors”) present their Annual Report together with the audited financial statements of the Chimera UCITS ICAV (the “ICAV”) for the financial year ended 31 December 2025 (the “financial year”).

Statement of Directors' Responsibilities

The Directors are responsible for preparing the Directors’ Report and financial statements of Chimera UCITS ICAV, in accordance with applicable law and regulations.

The Irish Collective Asset-Management Vehicles Act 2015 and 2020 (the “ICAV Act”) Section 116 requires the Directors to prepare financial statements for each financial year. Under that law they have elected to prepare the financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the European Union (“EU”) and applicable law.

Under the ICAV Act the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the assets, liabilities and financial position of the ICAV and of its changes in net assets attributable to holders of redeemable participating shares for that financial year. In preparing the financial statements, the Directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and estimates that are reasonable and prudent;

• state whether the financial statements have been prepared in accordance with IFRS and ensure that they contain the additional information required by the ICAV Act;

• assess the ICAV's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the ICAV will continue in business.

The Directors confirm that they have complied with the above requirements in preparing the financial statements.

The Directors are also responsible for safeguarding the assets of the ICAV and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Under the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations, 2011, as amended (the “UCITS Regulations”), the Central Bank (Supervision and Enforcement Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the “Central Bank UCITS Regulations”), the Directors are required to entrust the assets of the ICAV to a depositary for safekeeping. In carrying out this duty, the Directors have delegated custody of the ICAV’s assets to The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary”). They have general responsibility for taking such steps as are reasonably open to them to prevent and detect fraud and other irregularities. The Directors are also responsible for preparing a Directors’ Report that complies with the requirements of the ICAV Act.

Adequate Accounting Records

The ICAV has appointed FundRock Management Company S.A. as its Manager (the “Manager”) pursuant to the Management Agreement. Under the terms of the Management Agreement, the Manager has responsibility for the management and administration of the ICAV’s affairs and the distribution of the shares, subject to the overall supervision and control of the Directors.

The Manager has delegated the administration and transfer agency functions to an administrator and has therefore appointed BNY Mellon Fund Services (Ireland) Designated Activity Company to act as administrator (the “Administrator”), registrar and transfer agent of the ICAV with responsibility for performing the day to day administration of the ICAV.

The Directors believe that they have complied with the requirements of Sections 109 to 113 of the ICAV Act, with regard to keeping adequate accounting records in respect of the ICAV by appointing the Administrator which has appropriate expertise, adequate resources and appropriate systems and procedures. The accounting records of the ICAV are kept by the Administrator at their registered office at: The Shipping Office, 20-26 Sir John Rogerson's Quay, Grand Canal Dock, Dublin 2 D02 Y049, Ireland.

Page 6

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 4

Directors’ Report (continued)Corporate Governance StatementThe ICAV is subject to corporate governance practices imposed by:

(i) The ICAV Act, which is available for inspection at the registered office of the ICAV, and may also be obtained at http://www.irishstatutebook.ie;

(ii) The Instrument of Incorporation of the ICAV which is available for inspection at the registered office of the ICAV at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland;

(iii) The Central Bank of Ireland (“CBI”) in their UCITS Regulations which can be obtained from the CBI website at www.centralbank.ie and are available for inspection at the registered office of the ICAV.

From the inception of the ICAV, the Directors voluntarily adopted and applied the Irish Funds’ Corporate Governance Code (the “IF Code”) for Irish domiciled collective investment schemes and management companies as published by the Irish Funds, the full text of which is available from the Irish Funds’ website at www.irishfunds.ie. The ICAV has been fully compliant with the corporate governance practices during the financial year.

The ICAV is not subject to the amendments to general corporate law required by any European directives.

Composition and Operation of the Board of Directors

Unless otherwise determined by an ordinary resolution of the ICAV in general meeting and in accordance with Section 56 of the ICAV Act, the number of Directors may not be less than two or more than twelve. Currently the Board of Directors of the ICAV is composed of five Directors.

The business of the ICAV is managed by the Directors, who exercise all such powers of the ICAV which are not required by the ICAV Act or by the Instrument of Incorporation of the ICAV to be exercised by the ICAV in a general meeting. The Directors meet on a quarterly basis or more frequently, if required.

A Director may, and the Secretary of the ICAV on the requisition of a Director will, at any time summon a meeting of the Directors. Questions arising at any meeting of the Directors are determined by a majority of votes. In the case of an equality of votes, the Chairman has a second or casting vote. The quorum necessary for the transaction of business at a meeting of the Directors is two.

Directors and Secretary

The Directors that served at any time during the financial year are listed in the Directors and Other Information on page 1.

Bradwell Limited held the office of ICAV Secretary (the “Secretary”) throughout the financial year.

Directors’ Remuneration

The Board of Directors as a whole reviews Directors’ remuneration. The Director’s policy is that the remuneration of independent non-executive Directors should be fair and reasonable in relation to the time commitment and responsibilities of the Directors. The fees of the independent non-executive Directors are paid by the ICAV. The other Directors are not entitled to any fees.

Directors’ and Secretary’s Interests in Shares and Contracts

Other than as disclosed in Note 10 to the Financial Statements, none of the Directors, the Secretary nor their families had any interest in the shares of the ICAV at 31 December 2025, including a material interest in any contract or agreement of significance, as defined in the ICAV Act, during or at the end of the financial year in relation to the business of the ICAV.

Employees

The governance framework of the ICAV reflects the fact that it has no employees or subsidiary companies and outsources investment management, distribution and administration.

Page 7

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 5

Directors’ Report (continued)Transactions with Connected Persons

Regulation 43 of the Central Bank UCITS Regulations “Restrictions of transactions with connected persons” states that “A responsible person shall ensure that any transaction between a UCITS and a connected person is conducted a) at arm’s length; and b) in the best interest of the shareholders of the UCITS”.

As required under the Central Bank UCITS Regulation 81 (4), the Manager, as responsible person, has confirmed to the Board of Directors of the ICAV that it is satisfied that there are arrangements in place, evidenced by written procedures, to ensure that obligations set out in Regulation 43(1) are applied to all transactions with connected persons; and all transactions with connected persons that were entered into during the financial year to which the report relates, complied with the obligations that are prescribed by Regulation 43(1).

Principal Activities, Review of the Business and Future Developments

The ICAV is an open-ended Irish collective asset-management vehicle with segregated liability between Sub-Funds established under the laws of Ireland pursuant to the ICAV Act, the UCITS Regulations and the Central Bank UCITS Regulations. It was incorporated on 21 January 2019.

Each Sub-Fund may comprise one or more classes of shares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, establish further Sub-Funds by the issue of one or more separate classes of shares on such terms as the Directors may resolve.

As at 31 December 2025, the ICAV consisted of seven Sub-Funds - Chimera S&P UAE UCITS ETF (the "Sub-Fund"), launched on 23 February 2021; Chimera S&P Pakistan UCITS ETF (the "Sub-Fund), launched on 17 August 2023; Chimera JP Morgan UAE Bond UCITS ETF (the "Sub-Fund"), launched on 25 March 2024; Chimera S&P Japan UCITS ETF (the "Sub-Fund"), launched on 28 May 2024; Chimera S&P Germany UCITS ETF (the "Sub-Fund"), launched on 25 September 2024; Boreas Solactive Quantum Computing UCITS ETF (the "Sub-Fund"), launched on 19 September 2025; and Boreas S&P AI Data, Power and Infrastructure UCITS ETF (the "Sub-Fund"), launched 24 November 2025.

The Investment Manager's Report from pages 8 to 15 contains a review of the factors which contributed to the performance for the financial year ended 31 December 2025.

In respect of future developments for the ICAV, please refer to the subsequent events detailed in Note 21 of the financial statements.

Principal Risks and Uncertainties

The main risks arising from the ICAV's financial instruments are Investment strategy, Market Price Risk, Counterparty Credit & Settlement Risk, Foreign Currency Risk, Credit Risk, Interest Rate Risk, Liquidity Risk, Global Exposure and Fair Value which are outlined in Note 3 to these financial statements. Risk information is outlined in the Prospectus.

The maintenance and integrity of the financial statements published on the Chimera website are the Directors' responsibility, and may also be obtained at (https://www.chimerainvestment.com/Website/en/capitalllc.html).

Going Concern

The ICAV and Sub-Funds will continue in business and the financial statements have been prepared on a going concern basis.

Relevant Audit Information

So far as the Directors are aware, there is no relevant audit information of which the ICAV’s auditors are unaware and the Directors have taken all the steps that should have been taken as Directors in order to make themselves aware of any relevant audit information and to establish that the ICAV’s auditors are aware of that information.

Page 8

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 6

Directors’ Report (continued)Results and Dividends

The results for the financial year are set out in the Statement of Comprehensive Income. The Directors are empowered by the Instrument of Incorporation to declare and pay dividends, in respect of Shares in any Distributing Share Class out of net income (including dividend and interest income) and/or capital. Dividends paid out of capital are designed to a return or withdrawal of part of a Shareholder’s original investment or from any capital gains attributable to that original investment. It is not the current intention of the Directors to declare dividends in respect of the Sub-Funds.

Independent Auditors

Deloitte Ireland LLP, Chartered Accountants and Statutory Audit Firm, have indicated their willingness to continue as auditors in accordance with the ICAV Act 2015.

On behalf of the Board of Directors:Director: Director:Feargal Dempsey Syl O'ByrneDate: 22 April 2026

Page 9

The Bank of New York Mellon SA/NV, T +353 1 900 3500 Dublin Branch

The Shipping Office, 20-26 Sir John Rogerson’s Quay, Dublin 2, D02 Y049, Ireland.

Registered in Ireland No. 907126, VAT No. IE9578054E

The Bank of New York Mellon SA/NV, trading as The Bank of New York Mellon SA/NV, Dublin Branch is authorised by the National Bank of Belgium and regulated by the Central Bank of Ireland for conduct of business rules.

The Bank of New York Mellon SA/NV, Boulevard Anspachlaan 1, B-1000 Brussels Belgium – Tel. (32) 2 545 81 11, V.A.T. BE 0806.743.159-RPM-RPR Brussels Company No. 0806.743.159. The Bank of New York Mellon SA/NV is a Belgian limited liability company, authorized and regulated as a significant credit institution by the European Central Bank and the National Bank of Belgium under the Single Supervisory Mechanism and by the Belgian Financial Services and Markets Authority.

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025Report from the Depositary to the Shareholders

For the financial period from 1 January 2025 to 31 December 2025 (the “Period”). The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary” “us”, “we”, or “our”), has enquired into the conduct of Chimera UCITS ICAV (the “ICAV”) for the Period, in its capacity as depositary to the ICAV. This report including the opinion has been prepared for and solely for the Shareholders in the ICAV, in accordance with our role as depositary to the ICAV and for no other purpose. We do not, in giving this opinion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown.

Responsibilities of the Depositary

Our duties and responsibilities are outlined in Regulation 34 of the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (S.I. No 352 of 2011), as amended (the “Regulations”).

Our report shall state whether, in our opinion, the ICAV has been managed in that period in accordance with the provisions of the ICAV’s constitutional documents and the Regulations. It is the overall responsibility of the ICAV to comply with these provisions. If the ICAV has not been so managed, we as depositary must state in what respects it has not been so managed and the steps which we have taken in respect thereof.

Basis of Depositary Opinion

The Depositary conducts such reviews as it, in its reasonable opinion, considers necessary in order to comply with its duties and to ensure that, in all material respects, the ICAV has been managed (i) in accordance with the limitations imposed on its investment and borrowing powers by the provisions of its constitutional documentation and the appropriate regulations and (ii) otherwise in accordance with the ICAV’s constitutional documentation and the appropriate regulations.

Opinion

In our opinion, the ICAV has been managed during the Period, in all material respects:

(i) in accordance with the limitations imposed on the investment and borrowing powers of the ICAV by the constitutional documentation and by the Regulations; and

(ii) otherwise in accordance with the provisions of the constitutional documentation and the Regulations.


For and on behalf of The Bank of New York Mellon SA/NV, Dublin BranchDate: 22 April 2026

Page 10

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025

8Investment Manager’s Report

The Chimera UCITS ICAV Fund ended the second half of 2025 with assets under management of AED 311.7 million. As of the end of December, there are seven sub-funds under the Chimera UCITS ICAV Fund, of which one was launched in February 2021, one was launched in August 2023, three were launched in 2024 and the last two were launched in 2025. The sub-funds are the Chimera S&P UAE UCITS ETF (“the First Sub-Fund”), the Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”), the Chimera JP Morgan UAE Bond UCITS ETF (“the Third Sub-Fund”), the Chimera S&P Japan UCITS ETF (“the Fourth Sub- Fund”), Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”), the Boreas Solactive Quantum Computing UCITS ETF (“the Sixth Sub-Fund”) and the Boreas S&P AI Data, Power & Infrastructure UCITS ETF (“the Seventh Sub-Fund”).

Chimera S&P UAE UCITS ETF (“the First Sub-Fund”)

The Chimera S&P UAE UCITS ETF has two share classes launched on 23 February 2021, an accumulating share class listed on the Dubai Financial Market (DFM) that replicates the S&P UAE BMI Liquid 20/35 Capped Index NTR (Bloomberg Code:

SPUAECAN) and an income share class listed on the Abu Dhabi Securities Exchange (ADX) that replicates the S&P UAE BMI Liquid 20/35 Capped Index (Bloomberg Code: SPUAECAP). The dividends received by the fund’s income share class are intended to be distributed semi-annually when available.

As of 31st December 2025, the DFM-listed Share Class A (Bloomberg code: CHAE) had a NAV of AED 6.724, and the ADX-listed Share Class D (Bloomberg code: UAED*) had a NAV of AED 5.703.The return for the ETF for 2025 was 19.4% versus the S&P UAE BMI Liquid 20/35 Capped Index’s (the “Index”) return of 20.7%. Since inception, the fund’s return is 83.2% versus the index’s 92.8% return.

In the fourth quarter of 2025, a dividend of AED 0.0964 was announced for the ADX-listed Share Class D. This brings the total dividends for 2025 for the ETF to AED 0.2040 and translates into a yield of 3.6% based on the end-of-December NAV. The ex-dividend date was 22 December 2025, and the payment date is 12 January 2026.

*Ticker changed from CHAEIN to UAED in January 2025.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Page 11

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 9

Investment Manager’s Report (continued)

Chimera S&P UAE UCITS ETF (“the First Sub-Fund”) (continued) Tracking Difference & Tracking Error

The Fund's tracking difference in 2025 was -133.0bps, of which 80.2bps were management fees, resulting in a gross tracking difference of -52.8bps.

2021* 2022 2023 2024 2025 ITD

ETF Return35.1%-4.8%2.0%17.0%19.4%83.2%

Index Return36.4%-3.9%2.9%18.3%20.7%92.8%

Tracking Diff (bps)-133.1-90.3-98.0-129.3-133.0-956.3

Total Expense Ratio (bps)73.799.797.097.180.2454.9

Tracking Diff gross (bps)-59.49.4-1.0-32.2-52.8-501.4

Annualized Tracking Error (bps)33.613.613.410.623.620.0

*Since inception of fund on 23 February 2021.

As stated under the Investment Policy of the Chimera S&P UAE UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Worth noting that the total expense ratio for the fund was reduced from 1% to 0.6% effective July 25th, 2025.

Assets Under Management

The Assets Under Management (AUM) of the Chimera S&P UAE UCITS ETF Fund as of 31 December 2025 was AED 157.4 million. The AUM of Share Class D – Distributing (UAED), listed on the Abu Dhabi Securities Exchange (ADX) were AED 154.0 million, while the AUM of Share Class – A – Accumulating (CHAE), listed on the Dubai Financial Market (DFM) were AED 3.4 million as of 31 December 2025.

In 2025, the ADX-listed share class (UAED) saw AED 5.7 million in primary market activity and AED 5.9 million in secondary market trades. Meanwhile, the DFM-listed share class (CHAE) had no primary market activity but recorded AED 3.1 million in secondary market trades.

The S&P UAE BMI Liquid 20/35 Capped Index was rebalanced twice in the second half of 2025. In the third quarter, there were two additions and two deletions while the fourth quarter had three additions and three deletions implemented.

Market Commentary

The UAE economy has shown strong resilience against global uncertainties, regional tensions and oil market volatility. The IMF expects the UAE’s growth for 2025 to outpace regional and global averages supported by continued diversification and export expansion. The IMF projects UAE GDP growth to accelerate to 4.8% in 2025, up from an estimated 4% in 2024, driven by both non-hydrocarbon sectors and an uptick in oil production. Growth remains driven by ongoing expansion in tourism, construction, and financial services, bolstered by large-scale infrastructure developments. Growth is expected to accelerate to 5% in 2026.

Inflation is expected to remain subdued at around 1.6% in 2025, with housing costs being the primary pressure point in the consumer price index.

The IMF notes that UAE’s robust fiscal stance provides strong buffers to absorb shocks. The UAE is projected to stay resilient amid global policy uncertainty. Continued efforts to broaden Comprehensive Economic Partnership Agreements will strengthen this resilience and advance diversification, while financial markets and capital flows remain robust against global shocks, underscoring strong investor confidence.

Over 2025, sectors within the S&P UAE BMI Liquid 20/35 Capped Index delivered mixed returns. financials and information technology were the top contributors, with the sectors gaining 39.9% and 28.7%, respectively. On the other hand, consumer staples and health care were the worst performers losing 31.2% and 21.0%.

Page 12

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 10

Investment Manager’s Report (continued)Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”)

The Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. The fund replicates the S&P Pakistan BMI Liquid 20/35 Capped Index (Bloomberg code: SPPKRCAP), which tracks the performance of 15 of the most liquid stocks listed on the Pakistan Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: PKSTN*) – and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2025, the fund’s NAV was PKR 911.282 (AED 11.900). In 2025, the fund's return in PKR (the base currency) was 38.3% versus the S&P Pakistan BMI Liquid 20/35 Capped Index’s (the “Index”) return of 51.9%. Since inception, the fund’s return is 207.9% versus the index’s 228.5% return.

*Ticker changed from CHPKIN to PKSTN in January 2025.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Tracking Difference

The tracking difference for the Fund in 2025 was -1,359.5bps, of which 98.1bps is attributed to management fees, resulting in a gross tracking difference of -1,260.9bps. The underperformance relative to the index is primarily driven by structural inefficiencies in the local Pakistani market that impact ETF operations, due to the protracted timeframe required to receive dividend payments into the fund’s account. In addition, the fund incurred a realized capital gains tax, as well as a withholding tax, both of which contributed to the negative tracking difference. It is worth noting that the process of accruing capital gain taxes to the NAV started on October 29, 2025.

2023* 2024 2025 ITD

Fund Return**23.8%79.7%38.3%207.9%

Index Return**19.4%81.1%51.9%228.5

Tracking Diff (bps)442.0-135.9-1,359.5-2,065.1

Total Expense Ratio (bps)36.697.998.1233.6

Tracking Diff gross (bps)478.6-38.0-1,261.3-1,831.5

Annualized Tracking Error (bps)29.076.0197.6142.8

*Since inception of fund on 17 August 2023.

Page 13

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 11

Investment Manager’s Report (continued)Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”) (continued)Tracking Difference (continued)

**All returns are in base currency (PKR); Performance returns/figures previously reported in AED will now be reported in the base currency.

As stated under the Investment Policy of the Chimera S&P Pakistan UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Assets Under Management

As of 31 December 2025, the Chimera S&P Pakistan UCITS ETF had Assets Under Management (AUM) of PKR 991.3million (AED 11.9 million). During 2025, the ETF witnessed no primary activity. In the secondary market, the ETF traded for AED 0.9 million

There were neither addition nor deletions during the third quarter and the fourth quarter rebalancing of the S&P Pakistan BMI Liquid 20/35 Capped Index.

Market Commentary

Pakistan’s economy showed signs of stability and recovery with the economy expanding by 3% in the fiscal year ending June 2025 up from 2.6% in the previous year, according to the World Bank, reflecting a rebound in industrial activity and expansion in the services sector. Fiscal tightening and monetary policy helped stabilize inflation and maintain current and primary fiscal surpluses despite global and domestic challenges. Increased confidence boosted growth in industry and services, although agriculture lagged due to unfavorable weather and pest issues. Growth during the second half of calendar year is expected to be dampened by summer 2025 floods that caused severe damage to urban areas and agricultural land, significantly affecting communities.

In 2025, most of the sectors within the Chimera S&P Pakistan UCITS ETF gained. Financials, materials and utilities emerged as the best-performing sector within the ETF, gaining 130.5%, 76.2%, 75.4%, respectively, in PKR total return terms.

Chimera JP Morgan UAE Bond UCITS ETF (“the Third Sub-Fund”)

The Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. The fund aims to replicate the performance of the J.P Morgan MECI UAE Investment Custom Index, which tracks the performance of liquid, USD-denominated investment-grade instruments from the United Arab Emirates (UAE). The fund has one share class – Share Class D Distributing (Bloomberg code: BONDAE) – and interest received by the fund are intended to be distributed semi-annually when available.

The ETF ended 2025 with an NAV of USD 1.037 (AED 3.809). In 2025, the fund's return in USD (the base currency) was 7.7% versus the J.P Morgan MECI UAE Investment Custom Index’s (the “Index”) return of 8.6%.

During the second half of 2025, a dividend of USD 0.0229 was announced for the Chimera JP Morgan UAE Bond UCITS ETF.

This brings the total dividends for 2025 for the ETF to USD 0.0572 and translates into a yield of 5.51% based on the end-of- December NAV.

Page 14

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025

12Investment Manager’s Report (continued)

Chimera JP Morgan UAE Bond UCITS ETF (“the Third Sub-Fund”) (continued)

* The Fund and Index data specified in the graph are calculated since inception of the Fund Tracking Difference & Tracking Error

The Fund's tracking difference in 2025 was -88.7 bps, of which 49.3 bps is attributed to management fees, resulting in a gross tracking difference of -39.4 bps. In 2025, the annualized tracking error was 53.0 bps.

2024* 2025 ITD

Fund Return**1.9%7.7%9.8%

Index Return**3.1%8.6%12.0%

Tracking Diff (bps)-122.9-88.7-222.9

Total Expense Ratio (bps)38.649.387.8

Tracking Diff gross (bps)-84.3-39.4-135.1

Annualized Tracking Error (bps)62.253.057.2

*Since the inception of the fund on 25 March 2014.**All returns are in base currency (USD)

As stated under the Investment Policy of the Chimera JP Morgan UAE Bond UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference gross of fees shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Worth noting that the total expense ratio for the fund was reduced from 0.5% to 0.4% effective July 25th, 2025.

Assets Under Management

As of 31 December 2025, the Chimera JP Morgan UAE Bond UCITS ETF had Assets Under Management (AUM) of USD 4.7 million (AED 17.1 million). During 2025, the ETF witnessed a primary activity of AED 1.9 million. In the secondary market, the total traded value of the ETF traded for AED 4.8 million.

Page 15

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 13

Investment Manager’s Report (continued)

Chimera JP Morgan UAE Bond UCITS ETF (“the Third Sub-Fund”) (continued)

Assets Under Management (continued)

There were six monthly rebalancing of the J.P Morgan MECI UAE Investment Custom Index from July to December, resulting in a total of 11 additions and 2 deletions. Given that the ETF follows a sampling strategy, the ETF had 4 additions and 4 deletions during the same period due to index rebalancing.

Market Commentary

US economic growth remained resilient, driven primarily by strong consumption. Third-quarter 2025 GDP showed a 4.3% year-over-year increase, supported by robust service consumption while residential investments saw a decrease of -5.1% during the same period. The IMF expects the 2025 US growth rate to be 2% and to stay consistent in 2026 at 2.1%, citing lower effective tariff rates and a boost from supportive monetary policy.

In this context, the US Treasury curve has continued to steepen during the second half of 2025 as markets evaluate the trajectory of growth and inflation pushing global long-term yields higher. Abu Dhabi's CDS experienced fluctuations since July due to geopolitical tensions but closed the period at 27bps, near multi-decade lows.

Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”)

The Chimera S&P Japan UCITS ETF was launched on 28 May 2024. The fund replicates the S&P Japan BMI Liquid 35/20 Capped Index (Bloomberg code: SPJPLCAP), which tracks the performance of 30 of the most liquid stocks listed on the Tokyo Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: JPANI) – and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2025, the fund’s NAV was JPY 194.915 (AED 4.591). In 2025, the fund's return in JPY (the base currency) was 21.8%, compared to the S&P Japan BMI Liquid 35/20 Capped Index’s (the “Index”) return of 22.3%. Since inception, the fund’s return is 24.1% versus the index’s 24.2% return.

In the fourth quarter of 2025, a dividend of JPY 1.483 was announced for the Chimera S&P Japan UCITS ETF. This brings the total dividends for 2025 for the ETF to JPY 1.8297 and translates into a yield of 0.9% based on the end-of-December NAV. The ex-dividend date was 22 December 2025, and the payment date is 12 January 2026.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Page 16

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 14

Investment Manager’s Report (continued)

Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”) (continued) Tracking Difference

The Fund's tracking difference in 2025 was -47.0bps, of which 103.6bps is attributed to management fees, resulting in a gross tracking difference of 56.6bps.

2024* 2025 ITD

Fund Return**1.9%21.8%24.1%

Index Return**1.6%22.3%24.2%

Tracking Diff (bps)35.4-47.0-5.1

Total Expense Ratio (bps)57.0103.6154.7

Tracking Diff gross (bps)92.456.6149.6

Annualized Tracking Error (bps)22.037.032.3

*Since inception of the fund on 28 May 2024.**All returns are in base currency (JPY)

As stated under the Investment Policy of the Chimera S&P Japan UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.

Assets Under Management

As of 31 December 2025, the Chimera S&P Japan UCITS ETF had Assets Under Management (AUM) of JPY 487.3 million (AED 11.5 million). During the year, there was total primary trading activity of AED 4.5 million. In the secondary market, the ETF traded for AED 5.2 million.

The S&P Japan BMI Liquid 35/20 Capped Index was rebalanced twice in the second half of 2025. The third quarter rebalancing had three additions and three deletions and the fourth quarter rebalancing had four additions and four deletions.

Market Commentary

Japan’s economy expanded modestly in 2025, supported by domestic demand even as global headwinds persist. According to the OECD, Japan’s real GDP is projected to grow at 1.3% in 2025, driven mainly by private consumption and investment, while external demand exerts a slight drag due to global trade tensions. Similarly, the IMF projects growth of 1.1%, driven by an expected pickup in real wage growth supporting private consumption, despite headwinds from elevated trade policy uncertainty and softening external demand.

Political and policy developments played a role in shaping economic developments and expectations during the year. In October 2025, a new prime minister was appointed, leading a new government that has emphasized fiscal stimulus and growth-oriented policy initiatives. On monetary policy, Japan is continuing its exit from ultra-loose monetary policy, with 2 rate hikes in 2025, Bank of Japan lifted its policy rate to 0.75%.

During 2025, most of the sectors with the Chimera S&P Japan UCITS ETF gained. Communications services and financials were the best-performing sectors, reporting total returns of 42.7% and 36.0%, respectively, in JPY terms.

Page 17

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 15

Investment Manager’s Report (continued)Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”)

The Chimera S&P Germany UCITS ETF was launched on 25 September 2024. The fund replicates the S&P Germany BMI Liquid 35/20 Capped Index (Bloomberg code: SPDELCAP), which tracks the performance of 30 of the most liquid stocks listed on the German Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: GRMNY) – and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2025, the fund’s NAV was EUR 1.122 (AED 4.847). During 2025, the fund's return in EUR (the base currency) was 20.0%, compared to the S&P Germany BMI Liquid 35/20 Capped Index’s (the “Index”) return of 20.3%. Since inception, the fund’s return is 24.9% versus the index’s 25.6% return.

In the second quarter of 2025, a dividend of AED 0.0138 was announced for the ADX-listed Share Class D. This brings the total dividends for 2025 for the ETF to AED 0.0138 and translates into a yield of 1.2% based on the end-of-December NAV. The ex-dividend date was 30 June 2025, and the payment date was 21 July 2025.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Tracking Difference

The Fund's tracking difference in 2025 was -30.0bps, of which 97.5bps is attributed to management fees, resulting in a gross tracking difference of 67.5bps.

2024* 2025 ITD

Fund Return**4.0%20.0%24.9%

Index Return**4.4%20.3%25.6%

Tracking Diff (bps)-37.5-30.0-74.0

Total Expense Ratio (bps)26.397.5122.8

Tracking Diff gross (bps)-11.267.548.8

Annualized Tracking Error (bps)14.411.111.9

*Since the inception of the fund on 25 September 2024.

**All returns are in base currency (EUR)

Page 18

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 16

Investment Manager’s Report (continued)Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”) (continued)Tracking Difference (continued)

As stated under the Investment Policy of the Chimera S&P Germany UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.

Assets Under Management

As of 31 December 2025, the Chimera S&P Germany UCITS ETF had Assets Under Management (AUM) of EUR 2.8 million (AED 12.1 million). During the year, there was total primary trading activity of AED 6.1 million. In the secondary market, the ETF traded for AED 7.1 million.

The S&P Germany BMI Liquid 35/20 Capped Index was rebalanced twice in the second half of 2025. Both quarters had no additions or deletions.

Market Commentary

Germany’s economy grew modestly in 2025 following 2024 contraction amid ongoing structural headwinds and weak global demand. According to OECD’s economic outlook, Germany’s real GDP is projected to expand by around 0.3% in 2025 with private consumption supported by lower inflation and rising nominal wages but export oriented manufacturing facing continued uncertainty from trade pressures. National forecasts from German government also point to minimal growth of around 0.2%, with a gradual pick up expected in 2026 as public spending on infrastructure and defense boosts activity.

In March 2025, the German parliament reformed its fiscal rules to exempt defense spending above 1% of GDP and established a EUR 500 billion special fund for infrastructure and climate investment, easing fiscal constraints on the Federal states and allowing for high public investment in infrastructure, defense and green transition projects. While much of the fiscal stimulus is expected to materialize fully in the coming years, these policy shifts have already improved expectations for future growth and bolstered confidence in financial markets. The IMF has noted that the fiscal reform is set to provide a boost to growth driven by the driven by gradual acceleration of domestic investment and consumption.

During 2025, industrials and Utilities sectors emerged as the best-performing sectors within the Chimera S&P Germany UCITS ETF, reporting total returns of 55.7% and 54.7%, respectively, in EUR terms. On the contrary, consumer staples was the worst-performing sector during the same period, with negative returns of 23.8%.

Boreas Solactive Quantum Computing UCITS ETF (“the Sixth Sub-Fund”)

The Boreas Solactive Quantum computing UCITS ETF was launched on 19 September 2025. The fund replicates the Solactive Developed Quantum Computing Index (Bloomberg ticker: SOLQCMPN), which is composed of 25 stocks designed to capture the growth potential of quantum computing. The fund has one share class – Share Class B Income (Bloomberg code: QUANTM) which is listed in the ADX stock exchange– and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2025, the fund’s NAV was USD 0.540 (AED 1.983). From inception to the end of December 2025, the fund's return in USD (the base currency) was -2.7%, in line with the Solactive Developed Quantum Computing Index (the “Index”) return of -2.7%.

Page 19

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025

17Investment Manager’s Report (continued)

Boreas Solactive Quantum Computing UCITS ETF (“the Sixth Sub-Fund”) (continued)

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Tracking Difference

From inception to the end of December 2025, The Fund's tracking difference was -7.0bps, of which 14.0bps is attributed to management fees, resulting in a gross tracking difference of 6.9bps. During the same period, the annualized tracking error was 26.1 bps.

2025*Fund Return* -2.7%Index Return* -2.7%Tracking Diff (bps) -7.0Total Expense Ratio (bps) 14.0Tracking Diff gross (bps) 7.0Annualized Tracking Error (bps) 26.1

*All returns are in base currency (USD); figures since inception on 19 September 2025.

As stated under the Investment Policy of the Boreas Solactive Quantum computing UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.

Assets Under Management

As of 31 December 2025, the Boreas Solactive Quantum computing UCITS ETF had Assets Under Management (AUM) of USD 17.1 million (AED 33.9 million). During the year, there was total primary trading activity of AED 42.5 million. In the secondary market, the ETF traded for AED 17.3 million.

The Solactive Developed Quantum Computing Index was rebalanced once in the second half of 2025. The fourth quarter rebalancing had three additions and three deletions.

Page 20

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 18

Investment Manager’s Report (continued)

Boreas Solactive Quantum Computing UCITS ETF (“the Sixth Sub-Fund”) (continued)

Market Commentary

Quantum computing and quantum technologies continued to make significant progress in 2025, transitioning from theoretical research into tangible technological strides and commercial momentum with major players achieving verifiable breakthroughs and advancing practical applications. According to McKinsey leading firms and research teams achieved important milestones in error correction, qubit scaling and hardware performance, which are seen critical steps towards practical quantum advantage.

During the year, Pure-play quantum companies continued to make technological strides and funding momentum accelerated, supported by rising and private sector interest.

The investment landscape accelerated sharply in 2025 with both private capital and government funding fueling the growth.

According to McKinsey more than USD 10 billion of public funding was announced early in 2025, while at the same time, several private sector deals such as large funding rounds and strategic acquisitions took place. Those investments underpinned a rapidly growing ecosystem and helped position quantum technology as a key frontier for innovation, strategic competition and future economic value creation. McKinsey forecasts that quantum computing companies’ revenue in 2025 to surpass $1 billion driven by continuous growth in the deployment of quantum hardware across private industry and the defense sector.

Over 2025, Solactive Developed Quantum Computing Index gained 44.0% in total return. In terms of sectors performance was mixed. Communication services and information technology were the highest performing sectors, gaining 66.0% and 53.0%, respectively. On the other hand, materials and industrials were the worst performing sectors, dropping 36.7% and 18.1%.

Boreas S&P AI Data, Power & Infrastructure UCITS ETF (“the Seventh Sub-Fund”)

The Boreas S&P AI Data, Power & Infrastructure UCITS ETF was launched on 24 November 2025. The fund replicates the S&P Transatlantic AI-Related Data Center & Power Supply Infrastructure Index (Bloomberg ticker: SPTRDPUN), which is composed of 35 companies from the US and Developed European markets that provide the infrastructure underpinning the artificial intelligence (AI) industry. The fund has one share class – Share Class B Income (Bloomberg code: AIPOWR) which is listed in the ADX stock exchange– and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2025, the fund’s NAV was USD 0.562 (AED 2.065). From inception to the end of December 2025, the fund's return in USD (the base currency) was 1.3%, compared to the S&P Transatlantic AI-Related Data Center & Power Supply Infrastructure Index (the “Index”) return of 1.3%.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Page 21

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 19

Investment Manager’s Report (continued)

Boreas S&P AI Data, Power & Infrastructure UCITS ETF (“the Seventh Sub-Fund”) Tracking Difference

From inception to the end of December 2025, The Fund's tracking difference was -5.5bps, of which 6.3bps is attributed to management fees, resulting in a gross tracking difference of 0.8bps.

2025*Fund Return* 1.3%Index Return* 1.3%Tracking Diff (bps) -5.5Total Expense Ratio (bps) 6.3Tracking Diff gross (bps) 0.8Annualized Tracking Error (bps) 4.7

*All returns are in base currency (USD); figures since inception on 24 November 2025.

As stated under the Investment Policy of the Boreas S&P AI Data, Power & Infrastructure UCITS ETF, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.

Assets Under Management

As of 31 December 2025, the Boreas S&P AI Data, Power & Infrastructure UCITS ETF had Assets Under Management (AUM) of USD 18.5 million (AED 67.8 million). During the year, there was total primary trading activity of AED 68.9 million. In the secondary market, the ETF traded for AED 1.9 million.

Market Commentary

AI adoption has been accelerating rapidly, triggering an unprecedented surge in global computing demand. This boom is highlighting a structural need for massive new investment in energy systems, power grids, networks, data centers, and specialized AI infrastructure. Data centers are highly energy-intensive, and the strain they place on electricity systems is intensifying. The International Energy Agency (IEA) projects that global electricity demand from data centers will more than double to roughly 945 TWh by 2030, equivalent to Japan’s entire current annual power consumption. This surge in compute intensity has triggered record levels of capital expenditure in AI infrastructure by hyperscalers. Looking ahead, McKinsey expects the global AI related data center ecosystem to require USD 5.2 trillion in cumulative investment by 2030.

From the inception date of Boreas S&P AI Data, Power & Infrastructure UCITS ETF on 24 November 2025 until the end of December 2025, Industrials and Consumer discretionary emerged as the best-performing sectors within the ETF, recording total returns of 3.7% and 2.8%, respectively, in USD terms. On the contrary, Information Technology was the worst-performing sector during the same period, with negative returns of 2.5%.

Lunate Capital LimitedDate: February 2026

Page 22

Continued on next page/

Deloitte Ireland LLP Chartered Accountants & Statutory Audit

FirmINDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAVReport on the audit of the financial statements

Opinion on the financial statements of Chimera UCITS ICAV (the ‘ICAV’)

In our opinion the financial statements of the ICAV:

• give a true and fair view of the assets, liabilities and financial position of the Sub-Funds of the ICAV as at 31

December 2025 and of the results for the financial year then ended; and

• have been properly prepared in accordance with the relevant financial reporting framework and the applicable regulations.

The financial statements we have audited comprise:

• the Statement of Financial Position;

• the Statement of Comprehensive Income;

• the Statement of Changes in Net Assets attributable to Holders of Redeemable Participating Shares;

• the Statement of Cash Flows;

• the related notes 1 to 24, including material accounting policy information as set out in note 2; and

• the Schedule of Investments.

The relevant financial reporting framework that has been applied in their preparation is the Irish Collective Asset- Management Vehicles Acts 2015-2020 (“the ICAV Act”) and IFRS Accounting Standards as issued by the International Accounting Standards Board and as adopted by the European Union (“the relevant financial reporting framework”).

The applicable regulations which have been applied in their preparation are the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (as amended) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the “applicable regulations”).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (Ireland) (ISAs (Ireland)) and applicable law. Our responsibilities under those standards are described below in the “Auditor's responsibilities for the audit of the financial statements” section of our report.

We are independent of the ICAV in accordance with the ethical requirements that are relevant to our audit of the financial statements in Ireland, including the Ethical Standard issued by the Irish Auditing and Accounting Supervisory Authority (IAASA), as applied to public interest entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Page 23

/Continued from previous pageContinued on next page/INDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAVSummary of our audit approach

Key audit matters The key audit matters that we identified in the current financial year were:

• Valuation of financial assets at fair value through profit or loss

• Existence of financial assets at fair value through profit or loss

Materiality The materiality that we used in the current financial year was 0.5% (2024: 1%) of the average net assets for each Sub-Fund.

Scoping Our audit is a risk-based approach taking into account the structure of the ICAV, types of investments, the involvement of the third-party service providers, the accounting processes and controls in place and the industry in which the ICAV operates. We focused our audit scope and the extent of our testing, based on our assessment of the risks of material misstatement and of the materiality determined for each Sub-Fund.

Significant changesin our approach

There were no significant changes to our approach in respect to the current year.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Our evaluation of the directors’ assessment of the ICAV’s ability to continue to adopt the going concern basis of accounting included:

• obtaining an understanding of the relevant controls in place regarding going concern as part of our risk assessment procedures.

• challenging the reasonableness of the key assumptions applied by the directors in their assessment.

• holding discussions with management on the directors’ going concern assessment, the future plans for the ICAV and the feasibility of those plans.

• reviewed all board meeting minutes during the financial year up to the date of approval of the financial statements, for evidence of any discussions and/or decisions that could impact the ICAV’s ability to continue as a going concern.

• reviewing the capital activity and Net Asset Value movements of each Sub-Fund, subsequent to the financial year end.

• assessing the adequacy of the relevant going concern disclosures made in the financial statements.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the ICAV's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Key audit matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current financial year and include the most significant assessed risks of material misstatement (whether or not due to fraud) we identified, including those which had the greatest effect on: the overall audit strategy, the allocation of resources in the audit; and directing the efforts of the engagement team. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Page 24

/Continued from previous pageContinued on next page/INDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAV

Valuation of financial assets at fair value through profit or loss Key audit matter

description

As at 31 December 2025, the balance of each Sub-Fund’s financial assets at fair value through profit or loss represented majority of the total assets of each Sub-Fund.

While the nature of the financial assets at fair value through profit or loss do not require significant levels of judgement, their valuation is considered a key audit matter as it comprises the most significant balances on the Statement of Financial Position. The valuation of financial assets at fair value through profit or loss is also a key driver of the ICAV’s performance and the appropriate valuation is crucial to ensuring the financial statements are free from material misstatement.

Refer also to the relevant accounting policies and relevant note disclosures in relation to valuation of financial assets at fair value through profit or loss within notes 2(b) and 3 in the financial statements.

How the scope of ouraudit responded tothe key audit matter

We have performed the following procedures to address the key audit matter:

• We reviewed BNY Mellon Fund Services (Ireland) DAC’s SOC 1 Report and assessed the scope, sufficiency and results of the SOC 1 report to determine whether we could place reliance on this report for the purposes of design & implementation, with regard to the relevant controls over the valuation of financial assets at fair value through profit or loss;

• We independently valued financial assets at fair value through profit or loss by using independent market feeds. We compared the prices published by independent pricing sources to the investment portfolio; and

• We evaluated the adequacy of the relevant disclosures made in the financial statements.

Page 25

/Continued from previous pageContinued on next page/INDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAV

Existence of financial assets at fair value through profit or loss Key audit matter

description

As at 31 December 2025, the balance of each Sub-Fund’s financial assets at fair value through profit or loss represented majority of the total assets of each Sub-Fund.

The existence of financial assets at fair value through profit or loss is crucial to ensuring the financial statements are free from material misstatement and there is a risk that such financial assets may not exist at year end. The existence of financial assets at fair value through profit or loss involved significant audit effort in performing audit procedures and therefore is considered a key audit matter.

Refer to the relevant accounting policies and relevant note disclosures in relation to existence of financial assets at fair value through profit or loss within notes 2(b) and 3 in the financial statements.

How the scope ofour auditresponded to thekey audit matter

We have performed the following procedures to address the key audit matter:

• We reviewed BNY Mellon Fund Services (Ireland) DAC’s SOC 1 Report and assessed the scope, sufficiency and results of the SOC 1 report to determine whether we could place reliance on this report for the purposes of design & implementation, with regard to the relevant controls over the reconciliation of financial assets at fair value through profit or loss;

• We obtained independent confirmations from the depositary at the financial year end

and agreed the amounts held to the investment portfolio; and

• We evaluated the adequacy of the relevant disclosures made in the financial statements.

Our audit procedures relating to these matters were designed in the context of our audit of the financial statements as a whole, and not to express an opinion on individual accounts or disclosures. Our opinion on the financial statements is not modified with respect to any of the risks described above, and we do not express an opinion on these individual matters.

Our application of materiality

We define materiality as the magnitude of misstatement in the financial statements that makes it probable that the economic decisions of a reasonably knowledgeable person would be changed or influenced. We use materiality both in planning the scope of our audit work and in evaluating the results of our work.

Based on our professional judgement, we determined materiality for the financial statements as a whole as follows:

Basis fordeterminingmateriality0.5% of Average Net Assets of each Sub-Fund (2024: 1%)Rationale for thebenchmark applied

We have considered the Average Net Assets to be the critical component for determining materiality for each Sub-Fund because the main objective of each Sub-Fund is to provide shareholders with a total return and this would be deemed the most important measure for shareholders as the principal users of the financial statements.

We set performance materiality at a level lower than materiality to reduce the probability that, in aggregate,

Page 26

/Continued from previous pageContinued on next page/INDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAV

uncorrected and undetected misstatements exceed the materiality for the financial statements as a whole.

Performance materiality was set at 80% of materiality for the 2025 audit (2024: 50%). In determining performance materiality, we considered the following factors:

o our understanding of each Sub-Fund and the industry in which they operate, including knowledge gained in the previous audits;

o the quality of the ICAV’s internal control environment and whether we are able to rely on controls; o the nature and extent of misstatements identified in the previous audits; and

o our expectation of misstatements in the current year.

We agreed with the Board of Directors that we would report to them all audit differences in excess of 10% of materiality (2024: 5%), as well as differences below that threshold that, in our view, warranted reporting on qualitative grounds.

We also report to the Board of Directors on disclosure matters that we identified when assessing the overall presentation of the financial statements.

An overview of the scope of our audit

Our audit is a risk-based approach taking into account the structure of the ICAV, types of investments, the involvement of the third-party service providers, the accounting processes and controls in place and the industry in which the ICAV operates. The ICAV is incorporated as an Irish collective asset management vehicle with variable capital and authorised by the Central Bank of Ireland (the “CBI”) as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the applicable regulations. The ICAV is organised as an open-ended umbrella fund with segregated liability between Sub-Funds. We assess the risks of each Sub-Fund separately.

We have conducted our audit based on the books and records maintained by the administrator BNY Mellon Fund Services (Ireland) at One Dockland Central, Guild Street, IFSC, Dublin 1, Ireland.

Other information

The other information comprises the information included in the Annual Report & Audited Financial Statements, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the Annual Report & Audited Financial Statements.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.Responsibilities of directors

As explained more fully in the Statement of Directors’ Responsibilities, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view and otherwise comply with the ICAV Act.

The directors are also responsible for such internal control as the directors determine is necessary to enable the

Page 27

/Continued from previous pageContinued on next page/INDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAV

preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the ICAV’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the ICAV or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion.

Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (Ireland) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on IAASA’s website at: https://iaasa.ie/publications/description-of-the-auditors-responsibilities-for-the-audit-of-the-financial-statements.

This description forms part of our auditor’s report.

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Identifying and assessing potential risks related to irregularities

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following:

• the nature of the industry and sector, control environment and business performance;

• results of our enquiries of management and the Board of Directors about their own identification and assessment of the risks of irregularities;

• any matters we identified having obtained and reviewed the ICAV's documentation of their policies and procedures relating to:

o identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance;

o detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud;

o the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations; and

• the matters discussed among the audit engagement team and relevant internal specialists, including IT specialists regarding how and where fraud might occur in the financial statements and any potential indicators of fraud.

As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas:

• Risk of fraud in revenue recognition relating to the net change in unrealised gains/(losses) in fair value of financial assets at fair value through profit or loss.

In common with all audits under ISAs (Ireland), we are also required to perform specific procedures to respond to the risk of management override.

Page 28

/Continued from previous pageContinued on next page/INDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAV

We also obtained an understanding of the legal and regulatory framework that the ICAV operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the ICAV Act and the applicable regulations.

In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the ICAV’s ability to operate or to avoid a material penalty. These included the applicable listing rules.

Audit response to risks identified

As a result of performing the above, we did not identify any key audit matters related to the potential risk of fraud or non-compliance with laws and regulations.

In addition to the above, our procedures to respond to risks identified included the following:

• reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

• enquiring of management and the Board of Directors concerning actual and potential litigation and claims;

• performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;

• reading minutes of meetings of those charged with governance (Board of Directors);

• in addressing the risk of fraud in revenue recognition relating to the net change in unrealised gains/(losses) in fair value of financial assets at fair value through profit or loss, we recalculated the unrealised fair value movement on financial assets at fair value through profit or loss by performing a reconciliation and assessing the movement of the fair value of the financial assets at the Statement of Financial Position date from the previous financial year to the current financial year in order to determine the accuracy of the value recognised in the Statement of Comprehensive Income; and

• in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Report on other legal and regulatory requirements

Opinion on other matters prescribed by the ICAV Act and applicable regulations

In our opinion, the information given in the directors’ report is consistent with the financial statements and the directors’ report has been prepared in accordance with the ICAV Act.

Matters on which we are required to report by exception

Based on the knowledge and understanding of the ICAV and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report.

We have nothing to report in respect of the provisions in the ICAV Act which require us to report to you if, in our opinion, the disclosures of directors’ remuneration and transactions specified by law are not made.

Opinion on other matters prescribed by the applicable regulations

Based solely on the work undertaken in the course of the audit, we report that:

Page 29

/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE SHAREHOLDERS OFCHIMERA UCITS ICAV

• We have obtained all the information and explanations which we consider necessary for the purposes of our audit.

• In our opinion the accounting records of the ICAV were sufficient to permit the financial statements to be readily and properly audited.

• The financial statements are in agreement with the accounting records.

Other matters which we are required to address

We were appointed by the Board of Directors on 7 August 2020 to audit the financial statements for the financial period end date 30 June 2020. The period of total uninterrupted engagement including previous renewals and reappointments of the firm is 6 years, covering the periods ended 30 June 2020 to 31 December 2025.

The non-audit services prohibited by IAASA’s Ethical Standard were not provided and we remained independent of the company in conducting the audit.

Our audit opinion is consistent with the additional report to the Board of Directors we are required to provide in accordance with ISA (Ireland) 260.

Use of our report

This report is made solely to the ICAV’s shareholders, as a body, in accordance with Section 120(1) (b) of the ICAV Act.

Our audit work has been undertaken so that we might state to the ICAV’s shareholders those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the ICAV and the ICAV’s shareholders as a body, for our audit work, for this report, or for the opinions we have formed.

Sean GascoineFor and on behalf of Deloitte Ireland LLPChartered Accountants and Statutory Audit FirmDeloitte & Touche House, 29 Earlsfort Terrace, Dublin 2Date: 29 April 2026

Page 30

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 28

Statement of Financial PositionChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFAs at31 December2025As at31 December2024As at31 December2025As at31 December2024Notes AED AED PKR PKRAssets

Cash and cash equivalents6446,9962,883,67029,480,05321,901,444

Financial assets at fair value through profit or loss:

Transferable securities3157,152,812141,162,125958,768,369638,270,579

Total assets157,599,808144,045,795988,248,422660,172,023

Liabilities

Tax payable7––(74,596,918)–

Accrued Management fees10(258,571)(353,521)(2,369,314)(1,443,025)

Distributions Payable–(2,293,200)––

Total liabilities(258,571)(2,646,721)(76,966,232)(1,443,025)

Net assets attributable to holders of

redeemable participating shares14157,341,237141,399,074911,282,190658,728,998

Number of redeemable participating shares

Class A Accumulating Shares4500,000500,000––

Class D Distributing Shares427,000,00028,000,0001,000,0001,000,000

Net asset value per share attributable to holders of redeemable participating shares

Class A Accumulating Shares146.7245.632––

Class D Distributing Shares145.7034.949911.282658.729

The accompanying notes form an integral part of these financial statements.

Page 31

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 29

Statement of Financial Position (continued) Chimera JP

Morgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFAs at31 December2025As at31 December2024As at31 December2025As at31 December2024Notes USD USD JPY JPYAssets

Cash and cash equivalents6266,9026,577,9722,789,390

Financial assets at fair value through profit or loss:

Transferable securities34,617,3265,038,963486,011,816558,730,611

Dividends receivable19414213,12792,619

Interest income receivable53,78655,879––

Total assets4,671,3325,101,886492,602,915561,612,620

Liabilities

Securities purchase payable––(335,701)–

Accrued Management fees10(4,951)(7,016)(1,273,336)(1,541,148)

Distributions Payable––(3,707,500)–

Total liabilities(4,951)(7,016)(5,316,537)(1,541,148)

Net assets attributable to holders of

redeemable participating shares144,666,3815,094,870487,286,378560,071,472

Number of redeemable participating shares

Class D Distributing Shares44,500,0005,000,0002,500,0003,500,000

Net asset value per share attributable to holders of redeemable participating shares

Class D Distributing Shares141.0371.019194.915160.020

The accompanying notes form an integral part of these financial statements.

Page 32

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 30

Statement of Financial Position (continued) Chimera S&P

GermanyUCITS ETFChimera S&PGermanyUCITS ETFBoreas SolactiveQuantumComputingUCITS ETF*Boreas S&P AIData, Power andInfrastructureUCITS ETF**As at31 December2025As at31 December2024As at31 December2025As at31 December2025Notes EUR EUR USD USDAssets

Cash and cash equivalents613,91712,92237,56352,817

Financial assets at fair value through profit or loss:

Transferable securities32,799,4863,269,0959,206,78918,421,235

Dividends receivable––955,389

Total assets2,813,4033,282,0179,244,44718,479,441

Liabilities

Accrued Management fees10(7,314)(8,486)(13,780)(9,002)

Total liabilities(7,314)(8,486)(13,780)(9,002)

Net assets attributable to holders of

redeemable participating shares142,806,0893,273,5319,230,66718,470,439

Number of redeemable participating shares

Class B Distributing Shares4––17,100,00032,850,000

Class D Distributing Shares42,500,0003,500,000––

Net asset value per share attributable to holders of redeemable participating

shares

Class B Distributing Shares14––0.5400.562

Class D Distributing Shares141.1220.935––

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

On behalf of the Board of Directors:Director:______________________ Director:______________________Feargal Dempsey Syl O'ByrneDate: 24 April 2026

The accompanying notes form an integral part of these financial statements.

Page 33

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 31

Statement of Comprehensive IncomeChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Year1 January 2025to 31 December2025Financial Year1 January 2024to 31 December2024Financial Year1 January 2025to 31 December2025Financial Year1 January 2024to 31 December2024

AED AEDPKRPKR

Income

Dividend income7,132,9016,396,58353,648,72237,431,336

Net gains on financial assets at fair value

through profit or loss521,439,72415,553,206329,094,284290,114,841

Total investment income28,572,62521,949,789382,743,006327,546,177

Operating expenses

Management fees8,10(1,273,862)(1,274,167)(7,485,404)(4,564,927)

Capital gains taxes7––(82,483,873)(1,849,986)

Total operating expenses(1,273,862)(1,274,167)(89,969,277)(6,414,913)

Net income27,298,76320,675,622292,773,729321,131,264

Finance costsDistributions to holders of redeemable

participating shares16(5,615,600)(5,026,000)(32,866,800)(28,964,300)

Total finance costs(5,615,600)(5,026,000)(32,866,800)(28,964,300)

Profit for the financial year/period before

tax21,683,16315,649,622259,906,929292,166,964

Withholding tax––(7,353,737)–

Increase in net assets resulting fromoperations attributable to holders of

redeemable participating shares21,683,16315,649,622252,553,192292,166,964

Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of these financial statements.

Page 34

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 32

Statement of Comprehensive Income (continued) Chimera JP

Morgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFFinancial Year1 January 2025to 31 December2025Financial Period25 March 2024to 31 December2024Financial Year1 January 2025to 31 December2025Financial Period28 May 2024to 31 December2024

USD USDJPYJPY

Income

Interest income243,209218,586––

Dividend income2,51314210,472,8505,866,718

Net gains/(losses) on financial assets at fair

value through profit or loss5148,904(80,106)109,610,59211,044,582

Other income20162––

Total investment income394,646138,784120,083,44216,911,300

Operating expenses

Management fees8,10(22,642)(22,306)(5,349,610)(3,986,392)

Total operating expenses(22,642)(22,306)(5,349,610)(3,986,392)

Net income372,004116,478114,733,83212,924,908

Finance costsDistributions to holders of redeemable

participating shares16(286,000)–(4,920,950)–

Interest expense–(107)–(436)

Total finance costs(286,000)(107)(4,920,950)(436)

Profit for the financial year/period before

tax86,004116,371109,812,88212,924,472

Withholding tax––(1,595,476)–

Increase in net assets resulting fromoperations attributable to holders of

redeemable participating shares86,004116,371108,217,40612,924,472

Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of these financial statements.

Page 35

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 33

Statement of Comprehensive Income (continued) Chimera S&P

GermanyUCITS ETFChimera S&PGermanyUCITS ETFBoreas SolactiveQuantumComputingUCITS ETF*Boreas S&P AIData, Power andInfrastructureUCITS ETF**Financial Year1 January 2025to 31 December2025Financial Period25 September2024to 31 December2024Financial Period19 September2025to 31 December2025Financial Period24 November2025to 31 December2025

EUR EURUSDUSD

Income

Dividend income70,168513,75313,092

Net gains/(losses) on financial assets at fair

value through profit or loss5529,915135,500(104,182)229,340

Other income–12––

Total investment income/(expense)600,083135,517(90,429)242,432

Operating expenses

Management fees8,10(27,612)(8,486)(13,780)(9,002)

Capital gains taxes7––––

Other operating expenses(36)–––

Total operating expenses(27,648)(8,486)(13,780)(9,002)

Net income/(expense)572,435127,031(104,209)233,430

Finance costsDistributions to holders of redeemable

participating shares16(34,500)–––

Interest expense–––(50)

Total finance costs(34,500)––(50)

Profit/(loss) for the financial year/period

before tax537,935127,031(104,209)233,380

Withholding tax(14,377)–(4,126)(3,925)

Increase/(decrease) in net assets resultingfrom operations attributable to holders of

redeemable participating shares523,558127,031(108,335)229,455

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of these financial statements.

Page 36

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 34

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares Chimera S&P

UAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Year1 January 2025to 31 December2025Financial Year1 January 2024to 31 December2024Financial Year1 January 2025to 31 December2025Financial Year1 January 2024to 31 December2024

AED AEDPKRPKR

Net assets attributable to holders of redeemable participating shares at

beginning of the financial year/period141,399,074125,749,452658,728,998366,562,034

Increase in net assets resulting from operations attributable to holders of

redeemable participating shares21,683,16315,649,622252,553,192292,166,964

Issue of redeemable participating shares – – – – Redemption of redeemable participating

shares(5,741,000)–––

Decrease in net assets resulting from share

transactions(5,741,000)–––

Net assets attributable to holders ofredeemable participating shares at end of

the financial year/period157,341,237141,399,074911,282,190658,728,998

The accompanying notes form an integral part of these financial statements.

Page 37

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 35

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares (continued) Chimera JP

Morgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFFinancial Year1 January 2025to 31 December2025Financial Period25 March 2024to 31 December2024Financial Year1 January 2025to 31 December2025Financial Period28 May 2024to 31 December2024

USD USDJPYJPY

Net assets attributable to holders of redeemable participating shares at

beginning of the financial year/period5,094,870–560,071,472–

Increase in net assets resulting from operations attributable to holders of

redeemable participating shares86,004116,371108,217,40612,924,472

Issue of redeemable participating shares–6,500,000–942,000,000

Redemption of redeemable participating

shares(514,493)(1,521,501)(181,002,500)(394,853,000)

(Decrease)/increase in net assets resulting

from share transactions(514,493)4,978,499(181,002,500)547,147,000

Net assets attributable to holders of redeemable participating shares at end of

the financial year/period4,666,3815,094,870487,286,378560,071,472

The accompanying notes form an integral part of these financial statements.

Page 38

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 36

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares (continued) Chimera S&P

GermanyUCITS ETFChimera S&PGermanyUCITS ETFBoreas SolactiveQuantumComputingUCITS ETF*Boreas S&P AIData, Power andInfrastructureUCITS ETF**Financial Year1 January 2025to 31 December2025Financial Period25 September2024to 31 December2024Financial Period19 September2025to 31 December2025Financial Period24 November2025to 31 December2025

EUR EURUSDUSD

Net assets attributable to holders of redeemable participating shares at

beginning of the financial year/period3,273,531–––

Increase/(decrease) in net assets resulting from operations attributable to holders of

redeemable participating shares523,558127,031(108,335)229,455

Issue of redeemable participating shares544,0003,146,50010,476,54318,492,156

Redemption of redeemable participating

shares(1,535,000)–(1,137,541)(251,172)

(Decrease)/increase in net assets resulting

from share transactions(991,000)3,146,5009,339,00218,240,984

Net assets attributable to holders ofredeemable participating shares at end of

the financial year/period2,806,0893,273,5319,230,66718,470,439

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

The accompanying notes form an integral part of these financial statements.

Page 39

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 37

Statement of Cash FlowsChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Year1 January 2025to 31 December2025Financial Year1 January 2024to 31 December2024Financial Year1 January 2025to 31 December2025Financial Year1 January 2024to 31 December2024

AED AEDPKRPKR

Cash flows from operating activities

Proceeds from sale of investments127,162,49421,328,557189,229,21075,186,741

Purchase of investments1(27,454,456)(21,396,584)(188,519,671)(60,536,790)

Interest income received – – – –

Dividend income received7,132,9016,396,58346,294,98537,431,336

Operating expenses paid(1,368,813)(1,236,465)(6,559,115)(3,962,687)

Net cash inflow from operating activities5,472,1265,092,09140,445,40948,118,600

Cash flows from financing activities Distributions paid to holders of redeemable

participating shares16(7,908,800)(4,729,200)(32,866,800)(28,964,300)

Net cash outflow from financing activities(7,908,800)(4,729,200)(32,866,800)(28,964,300)

Net (decrease)/increase in cash and cash

equivalents(2,436,674)362,8917,578,60919,154,300

Cash and cash equivalents at beginning of

financial year/period2,883,6702,520,77921,901,4442,747,144

Cash and cash equivalents at end of the

financial year/period6446,9962,883,67029,480,05321,901,444

The accompanying notes form an integral part of these financial statements.

Page 40

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 38

Statement of Cash Flows (continued)Chimera JPMorgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFFinancial Year1 January 2025to 31 December2025Financial Period25 March 2024to 31 December2024Financial Year1 January 2025to 31 December2025Financial Period28 May 2024to 31 December2024

USD USDJPYJPY

Cash flows from operating activities

Proceeds from sale of investments14,475,7134,271,46082,549,23328,620,236

Purchase of investments1(3,894,975)(9,366,596)(80,886,645)(29,159,265)

Interest income received235,125138,774––

Dividend income received2,461–8,956,8665,774,099

Operating expenses paid(24,707)(15,128)(5,617,422)(2,445,244)

Net cash inflow/(outflow) from operating

activities793,617(4,971,490)5,002,0322,789,826

Cash flows from financing activities Distributions paid to holders of redeemable

participating shares16(286,000)–(1,213,450)–

Interest expense paid–(107)–(436)

Amounts received on issue of redeemable

participating shares1–6,500,000––

Amounts paid on redemption of redeemable

participating shares1(514,493)(1,521,501)––

Net cash (outflow)/inflow from financing

activities(800,493)4,978,392(1,213,450)(436)

Net (decrease)/increase in cash and cash

equivalents(6,876)6,9023,788,5822,789,390

Cash and cash equivalents at beginning of

financial year/period6,902–2,789,390–

Cash and cash equivalents at end of the

financial year/period6266,9026,577,9722,789,390

The accompanying notes form an integral part of these financial statements.

Page 41

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 39

Statement of Cash Flows (continued)Chimera S&PGermanyUCITS ETFChimera S&PGermanyUCITS ETFBoreas SolactiveQuantumComputingUCITS ETF*Boreas S&P AIData, Power andInfrastructureUCITS ETF**Financial Year1 January 2025to 31 December2025Financial Period25 September2024to 31 December2024Financial Period19 September2025to 31 December2025Financial Period24 November2025to31 December2025

EUR EURUSDUSD

Cash flows from operating activities

Proceeds from sale of investments1158,52137,9583,126,565250,265

Purchase of investments1(149,997)(25,053)(13,338,284)(18,442,160)

Interest income received – – – –

Dividend income received55,79159,5323,778

Operating expenses paid(28,820)12––

Net cash inflow/(outflow) from operating

activities35,49512,922(10,202,187)(18,188,117)

Cash flows from financing activities Distributions paid to holders of redeemable

participating shares16(34,500)–––

Interest expense paid–––(50)

Amounts received on issue of redeemable

participating shares1––10,239,75018,492,156

Amounts paid on redemption of redeemable

participating shares1–––(251,172)

Net cash (outflow)/inflow from financing

activities(34,500)–10,239,75018,240,934

Net increase in cash and cash equivalents99512,92237,56352,817

Cash and cash equivalents at beginning of

financial year/period12,922–––

Cash and cash equivalents at end of the

financial year/period613,91712,92237,56352,817

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

1 Chimera S&P UAE UCITS ETF engaged in in-kind redemptions of redeemable participating shares during the financial year amounting to AED 5,741,000 (31 December 2024: AED Nil) (refer to Notes 2(g) and 4 of the financial statements for further details). All redemptions out of the Sub-Fund for the financial year, were achieved via in kind withdrawal of assets of the same representing consideration for purchase and sale of investments.

1 Chimera S&P S&P Japan UCITS ETF engaged in in-kind subscriptions during the prior financial year amounting to JPY

942,000,000 and redemptions of redeemable participating shares during the financial year amounting to JPY181,002,500(31

December 2024: JPY 394,853,000) (refer to Notes 2(g) and 4 of the financial statements for further details). All subscriptions into and redemptions out of the Sub-Fund for the financial year, were achieved via in kind contribution and withdrawal of assets of the same representing consideration for purchase and sale of investments.

Page 42

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025

40Statement of Cash Flows (continued)

1 Chimera S&P S&P Germany UCITS ETF engaged in in-kind subscriptions and redemptions of redeemable participating shares during the financial year amounting to EUR 544,000 (31 December 2024: EUR 3,146,500) and EUR 1,535,000 (31 December 2024: EUR Nil) (refer to Notes 2(g) and 4 of the financial statements for further details). All subscriptions into and redemptions out of the Sub-Fund for the financial year, were achieved via in kind contribution and withdrawal of assets of the same amount representing consideration for purchase and sale of investments.

1 Boreas Solactive Quantum Computing UCITS ETF engaged in in-kind subscriptions and redemptions of redeemable participating shares during the financial period amounting to USD 236,793 and USD 1,137,541 (refer to Notes 2(g) and 4 of the financial statements for further details). All subscriptions into and redemptions out of the Sub-Fund for the financial period, were achieved via in kind contribution and withdrawal of assets of the same amount representing consideration for purchase and sale of investments.

The accompanying notes form an integral part of these financial statements.

Page 43

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025Notes to the Audited Financial Statements41

1. Organisation

Chimera UCITS ICAV (the ‘’ICAV’’) is an Irish collective asset-management vehicle registered in Ireland pursuant to the Irish Collective Asset-Management Vehicles Act 2015 (the “ICAV Act”) on 21 January 2019 with registration number C188915 and was authorised by the Central Bank of Ireland (the “CBI”) on 18 November 2020 as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the provisions of the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, (as amended) (the “UCITS Regulations”) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the “Central Bank UCITS Regulations”).

The ICAV is structured as an umbrella fund with segregated liability between Funds (individually a “Sub-Fund” and collectively “Sub-Funds”). The Instrument of Incorporation provides that the ICAV may offer separate classes of shares, each representing interests in a Sub-Fund comprising a distinct portfolio of investments. In addition, each Sub-Fund may be further divided into a number of different classes within the Sub-Fund. With the prior approval of the CBI, the ICAV from time to time may create additional Sub-Funds. The creation of further share classes shall be notified to and prepared and submitted to the CBI in accordance with the CBI requirements.

As at 31 December 2025, the ICAV consisted of seven Sub-Funds - Chimera S&P UAE UCITS ETF (the "Sub-Fund"), launched on 23 February 2021; Chimera S&P Pakistan UCITS ETF (the "Sub-Fund”), launched on 17 August 2023; Chimera JP Morgan UAE Bond UCITS ETF (the "Sub-Fund"), launched on 25 March 2024; Chimera S&P Japan UCITS ETF (the "Sub-Fund"), launched on 28 May 2024; and Chimera S&P Germany UCITS ETF (the "Sub-Fund"), launched on 25 September 2024; Boreas Solactive Quantum Computing UCITS ETF (the "Sub-Fund"), launched on 19 September 2025; and Boreas S&P AI Data, Power and Infrastructure UCITS ETF (the "Sub-Fund"), launched 24 November 2025.

The Sub-Funds seek to provide investors with a total return, taking into account capital and income returns, which reflects the returns of equity and bond indices called the S&P UAE BMI Liquid 20/35 Capped Index (the “Index”), the S&P Pakistan BMI Liquid 35/20 Capped Index (the "Index"), J.P. Morgan MECI UAE Investment Grade Custom Index (the "Index") , the S&P Japan BMI Liquid 35/20 Capped Index (the "Index") and the S&P Germany BMI Liquid 35/20 Capped Index (the "Index"), respectively.

The Index for Chimera S&P UAE UCITS ETF is a modified weighted total return index measuring the performance of 30 of the largest constituents of the S&P UAE BMI Index. The S&P UAE BMI Index is a leading benchmark for tracking performance of the UAE equity markets. The Index is comprised of the constituents of the S&P UAE BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a three-month average daily value traded volume of at least US$ 500,000 for at least one of the two quarterly periods preceding the rebalancing reference date.

The Index for Chimera S&P UAE UCITS ETF applies a UCITS capping screen of 20/35. This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer were justified by exceptional market conditions which may include the dominance of a particular issuer in the relevant market. The Index provider, S&P, has set triggers in place of at 33%/19% respectively to reset levels to ensure UCITS compliance at all times.

The Index of Chimera S&P Pakistan UCITS ETF is a modified weighted total return index measuring the performance of the top 15 Pakistan domiciled companies ranked in the S&P Pakistan BMI Index. The S&P Pakistan BMI Index is a leading benchmark for tracking performance of Pakistani companies. The Index is comprised of the top 15 constituents of the S&P Pakistan BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$200,000 for at least one of the two quarterly periods preceding the rebalancing reference date

The Index follows a six-month average daily traded value of >= $200,000. Stocks failing to meet this level will drop out of the Index once this liquidity screen fails to be met for the six-month period preceding the rebalancing reference date.

Page 44

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025Notes to the Audited Financial Statements (continued)42

1. Organisation (continued)

The Index of Chimera JP Morgan UAE Bond UCITS ETF is a subset of the J.P. Morgan Middle East Composite Index (MECI) (the "Parent Index"). The Index comprises the UAE investment grade USD-denominated corporate, quasi-sovereign and sovereign bond issues. The Parent Index is a leading index tracking the performance of USD-denominated debt in the Middle East. The index constituents must have a minimum face value outstanding of US$500 million, an outstanding maturity between one and two and a half years and bond ratings of BBB- or higher by at least two out of three ratings agencies of Standard & Poor's, Moody's and Fitch.

Index rebalancing occurs monthly on the last business day of each month. The Index applies a dual capping methodology, where all issuers are initially capped at 9.0%. The Index is then recalculated until all issuers are below the cap. The issuers above 4.5% are ranked, and the aggregate of these issuers must be below the 38.0% threshold, the highest ranked issuer that breaches the threshold and all remaining issuers in the index are capped at 4.5% after reweighting is applied. These reset triggers of 4.5%/9.0%/38.0% have been set by the Index Provider, JP Morgan, to ensure compliance with the UCITS diversification rules (ie. the 5/10/40 Rule) by creating a buffer below the regulatory limits.

The Index of Chimera S&P Japan UCITS ETF is modified weighted total return index measuring the performance of the top 30

Japan domiciled companies ranked in the S&P Japan BMI Index. The constituents of the S&P Japan BMI Index meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$1,000,000 for at least one of the two quarterly periods preceding the rebalancing reference date.

The Index applies a UCITS capping screen of 35%/20%. This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions which may include the dominance of a particular issuer in the relevant market.

The Index provider, S&P, has set triggers in place at 33%/19% respectively to reset levels to ensure UCITS compliance at all times.

The Index of Chimera S&P Germany UCITS ETF is a modified weighted total return index measuring the performance of the top 30 German domiciled companies ranked in the S&P Germany Index. The constituents of the S&P Germany BMI Index meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$1,000,000 for at least one of the two quarterly periods preceding the rebalancing reference date.

The Index applies a capping screen of 35%/20%. This will mean that the Sub-Fund, through investing in equity securities, may invest up to 20% of its net assets in a single security with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions such as a material price movement impacting the weighting of that single component within the Index and necessitating a larger exposure. The Index provider, S&P, has set triggers in place at 33%/19% respectively to reset levels to ensure UCITS compliance.

The Index of Boreas AI Data Power Supplement UCITS ETF is net total return index measuring the performance of data center and power supply infrastructure companies in the S&P Global BMI. The Index is comprised of constituents of the Parent Index that meet the following eligibility requirements: (i) Market Capitalisation: Companies must have a market cap greater than or equal to US$ 500 million; (ii) Liquidity: Companies must have a three-monthly daily value traded (“MDTV”) of US$ 2 million (US$ 1 million for existing Index Constituents); and (iii) Listing Venue: Companies must trade on Regulated Markets in the U.S.

or developed European countries.

This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market condition which may include the dominance of a particular issuer in the relevant market. The Index applies a single stock capping of 5% and single cluster weight cap of 25% to ensure diversification. The Index is rebalanced semi-annually, and in addition the index is re-weighted quarterly and resets exposure levels to ensure compliance with the UCITS Regulations.

The Index of Boreas Solactive Quantum Computing UCITS ETF is net total return index. The Index is currently comprised of 25 constituents that meet each of the following eligibility requirements: (i) Is a constituent of the Solactive GBS Developed Markets.All Cap USD Index PR (the “Parent Index”); (ii) Is listed on the following regulated market in the US or Europe:

a) US: companies must be listed on New York Stock Exchange (NYSE), NASDAQ, or NYSE America; and

b) Europe: companies must be listed on a regulated market in one of the “Developed European Countries”, as defined by the Solactive GBS Benchmark and which currently, at the date of this Supplement, includes: Austria; Belgium; Denmark; Finland;

Page 45

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 43

1. Organisation (continued)

France; Germany; Ireland; Italy; the Netherlands; Norway; Poland; Portugal; Spain; Sweden; Switzerland; and the United Kingdom.

The Fund, through investing in the equity securities, may invest up to 20% of its net assets in a single security with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions such as a material price movement impacting the weighting of that single component within the Index and necessitating a larger exposure. The Index provider applies a capping screen of 7.5% on issuers with a minimum market cap exceeding $500 million (the market cap threshold for existing constituents is $300 million) and a 2% cap on issuers with a market cap of $500 million or below (the market cap threshold for existing constituents is $300 million). The Index is rebalanced semi-annually and resets exposure levels to ensure compliance with the UCITS Regulations.

In order to achieve its investment objective, the investment policy of the Sub-Funds are to invest 100% of their net assets in a portfolio of equity and bond securities that consists of the equity and bond securities of each Index. Lunate Capital Limited (the "Investment Manager"), may deviate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.

The Sub-Funds attempt to replicate, before fees and expenses, the performance of each Index. The Investment Manager will seek to do this by replicating so far as possible the investments in each Index by holding all of the securities comprising each Index in approximately the same proportion as its weighting in each Index.

The base currency of Chimera S&P UAE UCITS ETF (the “Sub-Fund”), Chimera S&P Pakistan UCITS ETF (the “Sub- Fund"), Chimera JP Morgan UAE Bond UCITS ETF (the "Sub-Fund), Chimera S&P Japan UCITS ETF (the "Sub-Fund") and Chimera S&P Germany UCITS ETF (the "Sub-Fund”) Boreas Solactive Quantum Computing UCITS ETF (the "Sub-Fund"), Boreas S&P AI Data, Power and Infrastructure UCITS ETF (the "Sub-Fund") is the United Arab Emirates Dirham (“AED”), Pakistani Rupee ("PKR"), U.S. Dollar ("USD"), Japanese Yen ("JPY"), Euro ("EUR"), U.S. Dollar ("USD") and U.S. Dollar ("USD") respectively. The base currency of the ICAV is AED. The Net Asset Value per Share will be published and settlement and dealing will be affected in the designated currency of each Class.

The shares of the active Sub-Funds are listed and admitted for trading on the following stock exchanges: Class A Accumulating Shares are listed on the Dubai Financial Market while Class D Distributing Shares are listed on Abu Dhabi Securities Exchange.

2. Material Accounting Policies

(a) Basis of preparation

The ICAV’s annual report and audited financial statements have been prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board and as adopted by the European Union (“EU”), the ICAV Act, the UCITS Regulations and the Central Bank UCITS Regulations.

The financial statements have been prepared on a going concern basis which assumes that the ICAV will continue in operational existence for the foreseeable future and have been prepared under the historical cost convention, as modified by the revaluation of financial assets and financial liabilities at fair value through profit or loss.

In making the going concern assessment, the Directors have considered the level of subscriptions and redemptions during the financial year and the ICAV's ability to meet its payments as they fall due and assessed that any additional repayments may be met out of operating cash flows or raising further capital.

Use of judgements and estimates

The preparation of the annual report and audited financial statements in conformity with IFRS requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the reporting date and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates.

The Directors make estimates and assumptions concerning the future of the ICAV. The resulting accounting estimates will, by definition, seldom equal the related actual results. There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities.

Page 46

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 44

2. Material Accounting Policies (continued)

(a) Basis of preparation (continued)

International Financial Reporting Standards

New and revised IFRSs effective for accounting periods beginning on or after 1 January 2025

In the current period, the ICAV has applied a number of amendments to IFRS Standards and Interpretations issued by the International Accounting Standards Board (“IASB”) that are effective for an annual period that begins on or after 1 January 2025.

• Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates relating to Lack of Exchangeability.

Other than the above, there are no other significant IFRSs and amendments that were effective for the first time for the financial year beginning on or after 1 January 2025. The adoption of same did not have a significant impact on the ICAV's financial statements.

New and revised IFRSs in issue but not yet effective

The ICAV has not early adopted any new and revised IFRSs that have been issued by are not yet effective.

New and revised IFRSEffective for annualperiods beginningon or after

Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures regarding the classification and measurement of financial instruments

1 January 2026

Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures regarding purchase power arrangements

1 January 2026

Annual improvements to IFRS Accounting Standards - Volume 11 The pronouncement comprises the following amendments:

• IFRS 1: Hedge accounting by a first-time adopter

• IFRS 7: Gain or loss on derecognition

• IFRS 7: Disclosure of deferred difference between fair value and transaction price

• IFRS 7: Introduction and credit risk disclosures

• IFRS 9: Lessee derecognition of lease liabilities

• IFRS 9: Transaction price

• IFRS 10: Determination of a “de facto agent”

• IAS 7: Cost method

1 January 2026

IFRS 18 Presentation and Disclosures in Financial Statements 1 January 2027 IFRS 19 Subsidiaries without Public Accountability: Disclosures 1 January 2027 Amendments to IFRS 10 Consolidated Financial Statements and IAS 28 Investments in Associates and Joint Ventures (2011)

Effective date deferredindefinitely. Adoptionis still permitted.

The ICAV is currently evaluating the impact, if any, that these new and revised IFRS Standards will have on its financial statements.

The Manager anticipates that these IFRSs and amendments will be adopted in the financial statements in the initial period when they become mandatorily effective. The Manager assessed that adoption of these amendments will not have a significant impact on the ICAV’s financial statements.

There are no other standards, interpretations and amendments to existing standards in issue but not yet effective that would be expected to have a significant impact on the ICAV.

Page 47

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 45

2. Material Accounting Policies (continued)

(b) Financial assets and financial liabilities at fair value through profit or loss

(i) Classification

The ICAV classifies its investment portfolio based on its business model for managing those financial assets and the contractual cash flow characteristics of the financial assets. The portfolio of financial assets is managed and performance is evaluated on a fair value basis. The ICAV is primarily focused on fair value information and uses that information to assess the assets’ performance and to make decisions. The ICAV has not taken the option to irrevocably designate any equity securities as fair value through other comprehensive income. As such, the ICAV classifies its entire investment portfolio consisting of equities as financial assets at fair value through profit or loss.

Financial assets that are not classified at fair value through profit or loss include cash and cash equivalents and receivables.

Financial liabilities that are not at fair value through profit or loss include bank overdraft (if any) and payables. These other financial assets and financial liabilities are held at amortised cost.

(ii) Recognition, derecognition and measurement

Purchases and sales of investments are recognised on trade date basis, the date on which the ICAV commits to purchase or sell the asset. Financial assets and financial liabilities at fair value through profit or loss are initially recognised at fair value.

Transaction costs are expensed as incurred in the Statement of Comprehensive Income.

Investments are derecognised when the rights to receive cash flows from the investments have expired or the ICAV has transferred substantially all risks and rewards of ownership and a realised gain or loss is recognised. Realised gains and losses are presented in the Statement of Comprehensive Income under “net gain/(loss) on financial assets at fair value through profit or loss”.

Subsequent to initial recognition, all financial assets and financial liabilities at fair value through profit or loss are measured at fair value. Gains and losses arising from changes in the fair value of the financial assets or financial liabilities at fair value through profit or loss are presented in the Statement of Comprehensive Income within “net gain/(loss) on financial assets at fair value through profit or loss”.

(iii) Fair value estimation

Equity instruments listed, traded or dealt on a regulated market for which market quotations are readily available shall be valued at the last traded price at the valuation point in the relevant regulated market on the relevant dealing day, provided that the value of the investment listed, traded or dealt in on a regulated market but acquired or traded at a premium or at a discount outside or off the relevant stock exchange may be valued, taking into account the level of premium or discount as at the date of valuation of the investment and The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary”) must ensure that the adoption of such procedure is justifiable in the context of establishing the probable realisation value of the security.

If prices for an investment listed, traded or dealt in on the relevant regulated market are not available at the relevant time or are unrepresentative, or in the event that any investments are not listed or traded on any regulated market, such investment shall be valued at such value as shall be certified with care and good faith as the probable realisation value of the investment by a competent professional person appointed by the Directors and approved for such purpose by the Depositary which may be the Investment Manager.

In respect of Chimera JP Morgan UAE Bond UCITS ETF, the fixed income securities are valued on bid prices in the relevant regulated markets on the relevant trading day.

The ICAV recognises loss allowances of expected credit loss (“ECL”) on financial assets measured at amortised cost. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECLs, the ICAV considers reasonable and supportable information that is relevant and available without undue cost or effort.

This includes both quantitative and qualitative information and analysis, based on the ICAV's historical experience and informed credit assessment and including forward–looking information.ECLs are a probability–weighted estimate of credit losses. Credit losses are measured as the present value of all cash shortfalls (i.e. the difference between the cash flows due to the entity in accordance with the contract and the cash flows that the ICAV expects to receive). ECLs are discounted at the effective interest rate of the financial asset. The amount of expected credit losses is immaterial for financial assets.

Page 48

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 46

2. Material Accounting Policies (continued)

(c) Foreign currency translation

(i) Functional and presentation currency

The functional and presentation currency of Chimera S&P UAE UCITS is the United Arab Emirates Dirham (“AED”), that of Chimera S&P Pakistan UCITS ETF is Pakistani Rupee ("PKR"), that of Chimera JP Morgan UAE Bond UCITS ETF is US Dollar ("USD"), that of Chimera S&P Japan UCITS ETF is Japanese Yen ("JPY"), that of Chimera S&P Germany UCITS ETF is Euro ("EUR"), that of Boreas Solactive Quantum Computing UCITS ETF is US Dollar ("USD") and that of Boreas S&P AI Data, Power and Infrastructure UCITS ETF is US Dollar ("USD"). The functional currency of the Sub-Funds has been evaluated by the Directors based on the currency that most faithfully represents the economic effects of the underlying transactions, events, investors’ base and conditions.

The presentation currency of the ICAV is the AED.

(ii) Transactions and balances

Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at the closing rate of exchange at the year end date. Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of Comprehensive Income.

All other foreign currency exchange differences relating to monetary items, including cash are presented in the Statement of Comprehensive Income.

Non-monetary assets and liabilities denominated in foreign currencies that are measured at fair value are translated at the foreign currency exchange rates ruling at the dates that the values were determined.

(d) Transaction costs

Transaction costs are incurred on the acquisition or disposal of financial assets or financial liabilities at fair value through profit or loss. They include fees and commissions paid to agents, advisors, brokers and dealers, interest or taxes payable in respect of purchase and sale transactions. Transaction costs when incurred are expensed immediately and are included within net gain/loss on financial assets and financial liabilities at fair value through profit and loss in the Statement of Comprehensive Income. Please refer to Note 9 for more details.

(e) Dividend income

Dividends are credited to the Statement of Comprehensive Income on the dates on which the relevant securities are listed as “ex dividend”.

(f) Interest income and interest expense

Interest income on bonds and interest expenses are recognised in the Statement of Comprehensive Income on an effective yield basis.

(g) Redeemable participating shares

Redeemable participating shares are redeemable at the shareholder’s option and are classified as financial liabilities in accordance with IAS 32. Any distributions on these shares are recognised in the Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares.

The Primary Market is the market on which shares of the Sub-Funds are issued by the ICAV to Authorised Participants or redeemed by the ICAV from Authorised Participants. Only Authorised Participants are able to subscribe or redeem shares on the Primary Market.

Page 49

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 47

2. Material Accounting Policies (continued) (g) Redeemable participating shares (continued)

Subscriptions

Subscription of shares may be settled in cash, in-kind or in a combination of both, at the Manager’s discretion.

In-kind subscriptions

A Shareholder may subscribe for shares in-kind in a unit of the minimum subscription amount as set out in the relevant Supplement, or a multiple thereof, in return for a basket of component securities (“Component Securities”) and a cash component.

The Component Securities shall comprise some or all of the assets which may be invested in by the relevant Sub-Fund in accordance with the investment objective and policy of that Sub-Fund and the Depositary must be satisfied that there is unlikely to be any material prejudice to the existing Shareholders through the acceptance of the in-kind subscription.

Cash subscriptions

While subscriptions will normally only be accepted in-kind, the ICAV may on an exceptional basis accept subscription for shares in cash.

RedemptionsThe ICAV may pay redemptions either in kind or in cash.In-kind redemptions

A Shareholder may effect an in-kind redemption of their shares through an interdependent redemption process whereby (1) the ICAV shall agree to redeem a set number of shares in the ICAV; and (2) the Shareholder shall agree to purchase the underlying Component Securities at an agreed price.

Cash redemptions

While redemptions will normally only be in-kind, the ICAV may on an exceptional basis accept a request from a Shareholder to redeem Shares in cash.

Subscriptions and Redemptions (Secondary Market)

Shares may be purchased or sold on the Secondary Market by all investors through a relevant stock exchange on which the shares are admitted to trading or over the counter.

Shares of a Sub-Fund purchased on the Secondary Market cannot usually be sold directly back to the ICAV. Investors must buy and sell shares on a Secondary Market with the assistance of an intermediary (e.g. a broker) and may incur fees for doing so. In addition, investors may pay more than the current Net Asset Value when buying shares and may receive less than the current Net Asset Value when buying shares and may receive less than the current Net Asset Value when selling them.

(h) Expenses

Expenses are recognised in the Statement of Comprehensive Income on an accruals basis. Only management fees are charged to the Statement of Comprehensive Income and the Manager is responsible for discharging from the management fee, the other operational fees and expenses of the ICAV including Directors' fees but excluding establishment expenses which are borne by the Investment Manager.

(i) Gains/(losses) on financial assets and liabilities at fair value through profit or loss

All realised and unrealised gains and losses on securities are recognised as net gain/(loss) on financial assets and financial liabilities at fair value through profit or loss in the Statement of Comprehensive Income. The cost of securities sold is accounted for on an average cost basis.

Unrealised gains and losses consist of movement in the fair value of financial instruments between the opening and closing financial year. Realised gains and losses represent the difference between an instrument’s initial carrying amount and disposal amount, or cash payments.

Page 50

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 48

2. Material Accounting Policies (continued)

(j) Cash flows

The ICAV has prepared a Statement of Cash Flows using the direct method, whereby major classes of cash receipts and payments related to operating activities are disclosed.

(k) Dividend policy

The Sub-Funds offer Classes of shares that accumulate income or pay regular dividends out of net income and realised and unrealised gains net of realised and unrealised losses attributable to the relevant share class. The distribution of dividends is not guaranteed and is subject to the sole discretion of the Directors.

Accumulating Classes

The Directors currently do not intend to declare or pay dividends with respect to the accumulating classes of shares. Therefore, any net income and realised and unrealised gains net of realised and unrealised losses attributable to the shares of the accumulating classes of shares will be accumulated and reflected in their respective Net Asset Values per Share.

Distributing Classes

For the distributing classes of shares, the Directors may declare and pay dividends to the relevant Shareholders semi-annually on the distribution date. As the Index seek to track the price performance of the companies contained within the Index and distributions made and bond interest payments by those companies, dividends in respect of the distributing classes of shares will be calculated by reference to the embedded reinvested dividends within the Index during the relevant dividend period less taxes, including withholding taxes. As such, there is no guarantee that any dividend will be paid in respect of the distributing classes.

Dividends will be calculated so that any dividend declared will never be more than the excess performance of the total return performance of each Sub-Fund. The total return performance of each Sub-Fund is calculated by reference to the price return performance of each Index over the relevant calculation period (i.e. the relevant dividend period).

Such dividends shall be paid out of net income and realised and unrealised gains net of realised and unrealised losses attributable to the relevant share class of each Sub-Fund.

(l) Withholding tax

Dividend and interest income received by the ICAV may be subject to withholding tax imposed in the country of origin, which is shown separately in the Statement of Comprehensive Income.

(m) Capital gains taxes

In respect of Chimera S&P Pakistan UCITS ETF, the Sub-Fund is subject to Pakistani capital gains taxes, which are subject to a recognition on an accruals basis in the Sub-Fund's net asset value, effective from 29 October 2025.

(n) Cash and cash equivalents and bank overdrafts

Cash comprises of cash on hand and demand deposits. Cash equivalents, if any, are short term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to insignificant changes in value. Bank overdrafts are short term financing options which are repayable on demand. There were no bank overdraft balances at 31 December 2025 and 31 December 2024.

(o) Offsetting

Financial assets and financial liabilities are offset and the net amount reported in the Statement of Financial Position when there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle the liability simultaneously. As at 31 December 2025 and 31 December 2024, no financial assets and financial liabilities were offset in the Statement of Financial Position.

Income and expenses are presented on a net basis only when permitted under IFRS, for example, gains and losses from financial instruments at fair value through profit or loss and foreign exchange gains and losses.

Page 51

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 49

2. Material Accounting Policies (continued) (p) Establishment expenses

The cost of establishing the ICAV and its initial Sub-Funds and obtaining authorisation/approval from the Central Bank of Ireland were borne by the Investment Manager.

3. Financial Risk Management

(a) Investment strategy

Lunate Capital Limited acts as the Investment Manager to the Sub-Funds pursuant to the Management Agreement. The detailed investment objectives and policies of the Sub-Funds are set out in the Prospectus.

In order to achieve their investment objective, the investment policy of the Sub-Funds is to invest 100% of their net assets in a portfolio of equity and bond securities that consists of the equity and bond securities of the Index. The Investment Manager may deviate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.

The Sub-Funds attempts to replicate, before fees and expenses, the performance of the Index. The Investment Manager will seek to do this by replicating so far as possible the investments in the Index by holding all of the securities comprising the Index in approximately the same proportion as its weighting in the Index. The Investment Manager will monitor the Fund's tracking accuracy on a daily basis and will seek to maintain an appropriate correlation between the return of the Index and the return of the Fund. It is expected, but not guaranteed that the level of tracking error will be 0-2% in normal market conditions excluding Management Fees.

There can be no assurance that each Sub-Fund will achieve its investment objective. The value of shares and the income there from may rise or fall as the capital value of the equity securities in which the Sub-Funds invests may fluctuate. The investment income of the Sub-Funds are based on the income earned on the equity and bond securities they hold, less expenses incurred.

Therefore, the Sub-Funds’ investment income may be expected to fluctuate in response to changes in such income or expenses.

In pursuing its investment objective, the ICAV is exposed to a variety of risks: pricing and valuation risk, counterparty and settlement risk, foreign currency risk, credit risk, liquidity risk and other risks that could result in a reduction in the ICAV’s net assets. Risk information is outlined in the Prospectus.

The nature and extent of the financial instruments held at the reporting date and the risk management policies employed by the ICAV are discussed below.

(b) Market Price Risk

Market price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. The Sub-Funds are susceptible to market price risk arising from uncertainties about future prices of the instruments. The maximum risk resulting from financial instruments is determined by the fair value of the financial instruments.

Sensitivity Analysis

The tables below summarise the sensitivity of each equity Sub-Fund’s net assets attributable to holders of redeemable participating shares to market price movements. It shows the increase/(decrease) in the net assets attributable to holders of redeemable participating shares for each Sub-Fund’s given a 5% movement in the underlying investment prices at year-end; all other variables remaining constant (5% is considered to be a reasonable possible change in price):

Page 52

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 50

3. Financial Risk Management (continued) (b) Market Price Risk (continued)

Sensitivity Analysis (continued)31 December 2025Sub-Fund Currency 31 December 2025Chimera S&P UAE UCITS ETF AED 7,857,641Chimera S&P Pakistan UCITS ETF PKR 47,938,418Chimera JP Morgan UAE Bond UCITS ETF USD 227,412Chimera S&P Japan UCITS ETF JPY 24,300,591Chimera S&P Germany UCITS ETF EUR 139,974Boreas Solactive Quantum Computing UCITS ETF* USD 460,339Boreas S&P AI Data, Power and Infrastructure UCITS ETF** USD 921,062Sub-Fund Currency 31 December 2024Chimera S&P UAE UCITS ETF AED 7,058,106Chimera S&P Pakistan UCITS ETF PKR 31,913,529Chimera JP Morgan UAE Bond UCITS ETF USD 251,710Chimera S&P Japan UCITS ETF JPY 27,936,531Chimera S&P Germany UCITS ETF EUR 163,455

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

(c) Counterparty Credit & Settlement Risk

All security investments are transacted through brokers who have been approved by the Management Company as an acceptable counterparty. The list of approved brokers is reviewed regularly. There is a risk of loss if a counterparty fails to perform its financial or other obligations to the Sub-Funds, for example, the possibility that a counterparty may default, by failing to make payments due, or make payments in a timely manner. If settlement never occurs the loss incurred by the Sub-Fund will be the difference between the price of the original contract and the price of the replacement contract or, in the case where the contract is not replaced the absolute value of the contract at the time it is voided. Further, in some markets ‘Delivery versus Payment’ may not be possible in which case the absolute value of the contract is at risk if the Sub-Fund meets its settlement obligations but the counterparty fails before meeting its obligations.

As at 31 December 2025 and 31 December 2024, each Sub-Fund did not hold any forward exchange contracts.

(d) Foreign Currency Risk

Currency risk is the risk that the value of the Sub-Fund’s net assets will fluctuate due to changes in foreign currency rates.

Each Sub-Fund can hold assets denominated in currencies other than AED, PKR, USD, JPY and EUR, the functional currencies of same. They can therefore be exposed to currency risk, as the value of the securities denominated in other currencies will fluctuate due to changes in the exchange rates. As at 31 December 2025 and 31 December 2024, the Sub-Funds did not hold assets denominated in currencies other than AED, PKR, USD, JPY and EUR, the functional currencies of same. Therefore, the Sub-Funds were not materially exposed to currency risk at 31 December 2025 and31 December 2024 .

Page 53

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 51

3. Financial Risk Management (continued)

(e) Credit Risk

Credit risk is the risk that a counterparty or issuer will be unable to meet a commitment it has entered into with each Sub-Fund.

The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary”) has been appointed as Depositary to the ICAV.

Depending on the requirements of the jurisdictions in which the investments of the Sub-Fund are issued, the Depositary may use the services of one or more sub-custodians. Bankruptcy or insolvency of the Depositary may cause the Sub-Funds’ rights with respect to securities held to be delayed or limited. The Depositary is a branch of The Bank of New York Mellon SA/NV. The

Depositary held an AA- long term credit rating from the rating agency Standard and Poor’s as at 31 December 2025 (31

December 2024: AA-). The Depositary is responsible for the safe-keeping of the assets of the Sub-Funds.

The Depositary may, however, appoint any person or persons to be the sub-custodian of such assets but any liability of the Depositary shall not be affected by the fact that it has entrusted some or all of the assets in its safekeeping to any third party.

The Sub-Funds hold a proportion of their assets in cash. All securities transactions are cleared through and held in custody by the Depositary. The Sub-Funds are subject to the credit risk to the extent that this institution may be unable to fulfil its obligation either to return the Subs-Funds’ securities or repay amounts owed. For these financial instruments, the maximum credit risk amount at is represented by the amount at which they are included in the Statement of Financial Position. In the event of insolvency or bankruptcy of the Depositary or Broker, the Sub-Funds will be treated as general creditor in relation to cash held with the relevant Depositary or Broker.s at 31 December 2025 and 31 December 2024, the Sub-Funds’ financial assets exposed to credit risk amounted to the following:

Chimera S&P UAEUCITS ETFAs at 31 December2025AEDTransferable securities 157,152,812Cash and cash equivalents 446,996Total 157,599,808Chimera S&P UAEUCITS ETFAs at 31 December2024AEDTransferable securities 141,162,125Cash and cash equivalents 2,883,670Total 144,045,795Chimera S&PPakistanUCITS ETFAs at 31 December2025PKRTransferable securities 958,768,369Cash and cash equivalents 29,480,053Total 988,248,422

Page 54

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 52

3. Financial Risk Management (continued) (e) Credit Risk (continued)

Chimera S&PPakistanUCITS ETFAs at 31 December2024PKRTransferable securities 638,270,579Cash and cash equivalents 21,901,444Total 660,172,023Chimera JP MorganUAE BondUCITS ETFAs at 31 December2025USD

Transferable securities 4,617,326 Cash and cash equivalents 26

Other assets 53,980Total 4,671,332Chimera JP MorganUAE BondUCITS ETFAs at 31 December2024USDTransferable securities 5,034,202Cash and cash equivalents 11,663Other assets 56,021Total 5,101,886Chimera S&P JapanUCITS ETFAs at 31 December2025JPYTransferable securities 486,011,816Cash and cash equivalents 6,577,972Other assets 13,127Total 492,602,915Chimera S&P JapanUCITS ETFAs at 31 December2024JPYTransferable securities 558,730,611Cash and cash equivalents 2,789,390Other assets 92,619Total 561,612,620

Page 55

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 53

3. Financial Risk Management (continued) Chimera S&P Japan

UCITS ETFAs at 31 December2024Chimera S&PGermanyUCITS ETFAs at 31 December2025EURTransferable securities 2,799,486Cash and cash equivalents 13,917Total 2,813,403Chimera S&PGermanyUCITS ETFAs at 31 December2024EURTransferable securities 3,269,095Cash and cash equivalents 12,922Total 3,282,017Boreas SolactiveQuantum ComputingUCITS ETF*As at 31 December2025USDTransferable securities 9,206,789Cash and cash equivalents 37,563Other assets 95Total 9,244,447

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

Boreas S&P AI Data,Power andInfrastructureUCITS ETF**As at 31 December2025USDTransferable securities 18,421,235Cash and cash equivalents 52,817Other assets 5,389Total18,479,441

Page 56

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 54

3. Financial Risk Management (continued)

(e) Credit Risk (continued)

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31December 2024.

Details of Standard & Poor’s credit rating carried by investments held in interest bearing securities such as corporate and governments bonds, in Chimera JP Morgan UAE Bond UCITS ETF, as at 31 December 2025 and 31 December 2024 are disclosed in the table below.

2025AA 48%A 18%BBB 34%Total 100%AA 54%A 12%BBB 34%Total 100%

Page 57

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 55

3. Financial Risk Management (continued)

(f) Interest Rate Risk

This is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. With exception for Chimera JP Morgan UAE Bond UCITS ETF, the Sub-Funds’ financial assets are equity shares which neither pay interest nor have a maturity date; and cash balances that are not subject to significant interest rate risk.

Chimera JP Morgan UAE Bond UCITS ETF31 December 2025Up to 1-5 years Over Non-interest Total1 year 5 year bearing

USDUSDUSDUSDUSD

Assets

Cash and cash equivalents26–––26

Financial assets at fair value through

profit or loss69,0962,553,0351,995,195–4,617,326

Bond Interest receivable–––53,78653,786

Dividends receivable–––194194

Total Assets69,1222,553,0351,995,19553,9804,671,332

Liabilities

Accrued Management fees–––(4,951)(4,951)

Total Liabilities–––(4,951)(4,951)

Total interest sensitivity gap69,1222,553,0351,995,19549,0294,666,381

31 December 2024

Up to 1-5 years Over Non-interest Total 1 year 5 year bearing

USDUSDUSDUSDUSD

Assets

Cash and cash equivalents6,902–––6,902

Financial assets at fair value throughprofit or loss

65,0762,726,3832,247,504–5,038,963

Bond Interest receivable–––55,87955,879

Dividends receivable–––142142

Total Assets71,9782,726,3832,247,50456,0215,101,886

Liabilities

Accrued Management fees–––(7,016)(7,016)

Total Liabilities–––(7,016)(7,016)

Total interest sensitivity gap71,9782,726,3832,247,50449,0055,094,870

For Chimera JP Morgan UAE Bond UCITS ETF, as at 31 December 2025 and 31 December 2024, had interest rates risen by 25 basis points ("bps") with all other variables remaining constant, the interest bearing assets of the Sub-Fund could be expected to decrease by no more than 25 bps, resulting in a decrease of USD 64,016 (31 December 2024: USD 73,489). A 25 bps fall in interest rates would have resulted in an equal but opposite effect. Alternatively, based on an average duration of 5.63 at 31

December 2025 (5.91 at 31 December 2024), had interest rates risen by 25 basis points, this would result in a Fund Total Return - Instantaneous Shift of 1.41% (31 December 2024: 1.48%).

Page 58

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 56

3. Financial Risk Management (continued)

(g) Liquidity Risk

In normal market conditions the assets of each Sub-Fund comprise mainly realisable investments which can be readily sold. A Sub-Fund’s main liability is the redemption of any shares that investors wish to sell. In general, the investments, including cash, of each Sub-Fund are managed so that it can meet its liabilities. Investments held may need to be sold if insufficient cash is available to finance such redemptions. If the size of the disposals are sufficiently large, or the market is illiquid, then there is a risk that either the investments might not be sold or the price at which they are sold may adversely affect the Net Asset Value of a Sub-Fund. The ICAV employs an appropriate liquidity risk management process, which takes into account efficient portfolio management transactions employed by the Sub-Funds, in order to ensure that each Sub-Fund is able to comply with its stated redemption obligations. However, it is possible that in the type of circumstances described above, a Sub-Fund may not be able to realise sufficient assets to meet all redemption requests that it receives or the ICAV may determine that the circumstances are such that meeting some or all of such requests is not in the best interests of the Shareholders in a Sub-Fund as a whole. In such circumstances, the settlement of redemption proceeds may be delayed and / or the ICAV may take the decision to apply the redemption gate provisions described under “Procedure for Dealing on the Primary Market” in the “Purchase and Sale Information” section or suspend dealings in the relevant Sub-Fund as described under “Temporary Suspension of Dealings” in the “Determination of Net Asset Value” section of the Prospectus.

The following table analyses the ICAV’s financial assets and liabilities into relevant maturity groupings based on the remaining year, at the financial years ended 31 December 2025 and 31 December 2024, to the contractual maturity date.

Chimera S&P UAE UCITS ETFAs at 31 December 2025 Less than1 month Total

AEDAED

Accrued Management fees258,571258,571

Net assets attributable to holders of redeemable participating shares157,341,237157,341,237

157,599,808160,202,608

Chimera S&P UAE UCITS ETF

As at 31 December 2024 Less than 1 month Total

AEDAED

Accrued Management fees353,521353,521

Distributions Payable2,293,2002,293,200

Net assets attributable to holders of redeemable participating shares141,399,074141,399,074

144,045,795144,045,795

Chimera S&P Pakistan UCITS ETF As at 31 December 2025 Less than 1 month Total

PKRPKR

Accrued Management fees2,369,3142,369,314

Tax payable74,596,91874,596,918

Net assets attributable to holders of redeemable participating shares911,282,190911,282,190

988,248,422988,248,422

Chimera S&P Pakistan UCITS ETF As at 31 December 2024 Less than 1 month Total

PKRPKR

Accrued Management fees1,443,0251,443,025

Net assets attributable to holders of redeemable participating shares658,728,998658,728,998

660,172,023660,172,023

Page 59

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 57

3. Financial Risk Management (continued) (g) Liquidity Risk (continued)

Chimera JP Morgan UAE Bond UCITS ETF As at 31 December 2025 Less than 1 month Total

USDUSD

Accrued Management fees4,9514,951

Net assets attributable to holders of redeemable participating shares4,666,3814,666,381

4,671,3324,671,332

Chimera JP Morgan UAE Bond UCITS ETF As at 31 December 2024 Less than 1 month Total

USDUSD

Accrued Management fees7,0167,016

Net assets attributable to holders of redeemable participating shares5,094,8705,094,870

5,101,8865,101,886

Chimera S&P Japan UCITS ETF

As at 31 December 2025 Less than 1 month Total

JPYJPY

Securities purchased payable335,701335,701

Accrued Management fees1,273,3361,273,336

Distributions Payable3,707,5003,707,500

Net assets attributable to holders of redeemable participating shares487,286,378487,286,378

492,602,915492,602,915

Chimera S&P Japan UCITS ETF

As at 31 December 2024 Less than 1 month Total

JPYJPY

Accrued Management fees1,541,1481,541,148

Net assets attributable to holders of redeemable participating shares560,071,472560,071,472

561,612,620561,612,620

Chimera S&P Germany UCITS ETF

As at 31 December 2025 Less than 1 month Total

EUREUR

Accrued Management fees7,3147,314

Net assets attributable to holders of redeemable participating shares2,806,0892,806,089

2,813,4032,813,403

Chimera S&P Germany UCITS ETF

As at 31 December 2024 Less than 1 month Total

EUREUR

Accrued Management fees8,4868,486

Net assets attributable to holders of redeemable participating shares3,273,5313,273,531

3,282,0173,282,017

Page 60

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 58

3. Financial Risk Management (continued) (g) Liquidity Risk (continued)

Boreas Solactive Quantum Computing UCITS ETF* As at 31 December 2025 Less than

1 month Total

USDUSD

Accrued Management fees13,78013,780

Net assets attributable to holders of redeemable participating shares9,230,6679,230,667

9,244,4479,244,447

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

Boreas S&P AI Data, Power and Infrastructure UCITS ETF**As at 31 December 2025 Less than1 month Total

USDUSD

Accrued Management fees9,0029,002

Net assets attributable to holders of redeemable participating shares18,470,43918,470,439

18,479,44118,479,441

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

(h) Global Exposure

Global Exposure refers to the measure of each Sub-Fund's risk exposure that factors in the market risk exposure of underlying investments, inclusive of the implied leverage associated with financial derivative instruments ("FDIs") held in the portfolio.

Under the UCITS Regulations, a Sub-Fund is required to use either a “Commitment Approach” or a “Value-at-Risk (VaR) Approach” to measure their Global Exposure. VaR is a statistical methodology that predicts, using historical data, the maximum potential daily loss of a Sub-Fund that can arise at a given confidence level over a specific time period under normal market conditions. VaR may be expressed in absolute terms as a percentage of each Sub-Fund’s assets or in relative terms, where the VaR of each Sub-Fund is divided by the VaR of its relevant benchmark, generating a ratio known as relative VaR. The Commitment Approach represents a methodology to measure global exposure based on the calculation of the portfolio leverage which includes the netting and hedging of FDI that each Sub-Fund may have in place according to the UCITS Regulations. A Sub-Fund, which is using the Commitment Approach to measure its Global Exposure, is limited to 100% commitment leverage.

The Sub-Funds employ the Commitment Approach. The Sub-Funds’ global exposure (as prescribed in the Central Bank UCITS Regulations) relating to FDI’s shall not exceed 100% of the NAV of each Sub-Fund and will be measured using the Commitment Approach. The Commitment Approach methodology aggregates the underlying market or notional values of FDIs to determine the degree of global exposure of the Sub-Funds to FDIs.

The Manager has a risk management process in respect of the Sub-Funds which enables it to accurately measure, monitor and manage the various risks associated with FDI, the use of efficient portfolio management techniques and the management of collateral. The Investment Manager will only employ FDI that are covered by the risk management process, as amended from time to time. A statement of this risk management process has been submitted to and cleared by the Central Bank.

In the event of a Sub-Fund proposing to use additional types of FDI, the risk management process and the relevant Supplement will be amended to reflect this intention and the Sub-Fund will not utilise such FDI until such time as the risk management process providing for its use has been submitted to and cleared by the Central Bank. The Manager will, on request, provide supplementary information to shareholders relating to the risk management methods employed including the quantitative limits that are applied and any recent developments in the risk and yield characteristics of the main categories of investment.

Page 61

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 59

3. Financial Risk Management (continued)

(i) Fair Value

IFRS 13 ‘Fair Value Measurement' requires disclosure relating to the fair value hierarchy in which fair value measurements are categorised as assets and liabilities in the Statement of Financial Position.

The disclosures are based on a three-level fair value hierarchy for the inputs used in valuation techniques to measure fair value.

The fair value of financial assets and financial liabilities traded in an active market (such as trading securities) are based on quoted market prices at the close of trading on the reporting date.

A financial instrument is regarded as quoted in an active market if the quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm's length basis. These instruments are included within Level 1 of the hierarchy.

The fair value of financial assets and financial liabilities that are not traded in an active market is determined by using valuation techniques. The ICAV uses a variety of methods and makes assumptions that are based on market conditions existing at the reporting date. These instruments are included within Level 2 of the hierarchy. The fair value hierarchy has the following levels:

• Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

• Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (Level 2).

• Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).

Transfers are deemed to occur at the end of the financial year.

There were no transfers between levels during the financial years ended 31 December 2025 and 31 December 2024 for the Sub- Funds.

The tables overleaf provide an analysis of financial instruments at 31 December 2025 and 31 December 2024 that are measured at fair value in accordance with IFRS 13:

Page 62

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 60

3. Financial Risk Management (continued)

(i) Fair Value (continued)

Chimera S&P UAE UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2024

Level 1 Level 2 Level 3 Total

AEDAEDAEDAED

Transferable securities

Equities157,152,812––157,152,812

Total157,152,812––157,152,812

Chimera S&P UAE UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2024

Level 1 Level 2 Level 3 Total

AEDAEDAEDAED

Transferable securities

Equities141,162,125––141,162,125

Total141,162,125––141,162,125

Chimera S&P Pakistan UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2025

Level 1 Level 2 Level 3 Total

PKRPKRPKRPKR

Transferable securities

Equities958,768,369––958,768,369

Total958,768,369––958,768,369

Chimera S&P Pakistan UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2024

Level 1 Level 2 Level 3 Total

PKRPKRPKRPKR

Transferable securities

Equities638,270,579––638,270,579

Total638,270,579––638,270,579

Page 63

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 61

3. Financial Risk Management (continued)

(i) Fair Value (continued)

Chimera JP Morgan UAE Bond UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2025

Level 1 Level 2 Level 3 Total

USDUSDUSDUSD

Transferable securities

Corporate Bonds–3,948,143–3,948,143

Government Bonds–600,087–600,087

Mutual Funds69,096––69,096

Total69,0964,548,230–4,617,326

Chimera JP Morgan UAE Bond UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2024

Level 1 Level 2 Level 3 Total

USDUSDUSDUSD

Transferable securities

Corporate Bonds–4,274,698–4,274,698

Government Bonds–699,189–699,189

Mutual Funds65,076––65,076

Total65,0764,973,887–5,038,963

Chimera S&P Japan UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2025

Level 1 Level 2 Level 3 Total

JPYJPYJPYJPY

Transferable securities

Equities486,011,816––486,011,816

Total486,011,816––486,011,816

Chimera S&P Japan UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2024

Level 1 Level 2 Level 3 Total

JPYJPYJPYJPY

Transferable securities

Equities558,730,611––558,730,611

Total558,730,611––558,730,611

Page 64

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 62

3. Financial Risk Management (continued)

(i) Fair Value (continued)

Chimera S&P Germany UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2025

Level 1 Level 2 Level 3 Total

EUREUREUREUR

Transferable securities

Equities2,799,486––2,799,486

Total2,799,486––2,799,486

Chimera S&P Germany UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2024

Level 1 Level 2 Level 3 Total

EUREUREUREUR

Transferable securities

Equities3,269,095––3,269,095

Total3,269,095––3,269,095

Boreas Solactive Quantum Computing UCITS ETF*Financial Assets at Fair Value through Profit or LossAs at 31 December 2025Level 1 Level 2 Level 3 Total

USDUSDUSDUSD

Transferable securities

Equities9,206,789––9,206,789

Total9,206,789––9,206,789

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

Boreas S&P AI Data, Power and Infrastructure UCITS ETF**Financial Assets at Fair Value through Profit or LossAs at 31 December 2025Level 1 Level 2 Level 3 Total

USDUSDUSDUSD

Transferable securities

Equities18,421,235––18,421,235

Total18,421,235––18,421,235

Page 65

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 63

3. Financial Risk Management (continued)

(i) Fair Value (continued)

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

Assets and liabilities not carried at fair value but for which fair value is disclosed

All other assets and liabilities, including cash and cash deposits, are carried at amortised cost and their carrying values are a reasonable approximation of fair value. At such, Level 2 is deemed to be the most appropriate categorisation.

Cash and cash equivalents include cash on hand and demand deposits held with banks and brokers.

4. Share Capital

The issued share capital of the ICAV shall be not less than the currency equivalent of €2 represented by two subscriber shares of no par value and the maximum issued share capital of the ICAV shall not be more than 500 billion shares of no par value. The share capital of the ICAV shall at all times equal the Net Asset Value of the ICAV.

Subscriber shares entitle the holders to attend and vote at all meetings of the ICAV but do not entitle the holders to participate in the dividends or net assets of any Sub-Fund or of the ICAV. The holders of the subscriber shares shall have one vote for each subscriber share held.

Each of the redeemable shares entitles the Shareholder to participate equally on a pro rata basis in the dividends and net assets of a Sub-Fund attributable to the relevant Class in respect of which they are issued, save in the case of dividends declared prior to becoming a Shareholder.

The Directors reserve the right to predesignate any class of shares from time to time, provided that Shareholders in that class shall first have been notified by the ICAV thirty calendar days in advance that the shares will be predesignated and shall have been given the opportunity to have their shares redeemed by the ICAV, except that this requirement shall not apply where the Directors predesignate shares in issue in order to facilitate the creation of an additional class of shares.

Each of the redeemable shares entitles the holder to attend and vote at meetings of the ICAV and of the relevant Sub-Fund represented by those shares. No class of shares confers on the holder thereof any preferential or pre-emptive rights or any rights to participate in the profits and dividends of any other class of shares or any voting rights in relation to matters relating solely to any other class of shares.

Any resolution to alter the class rights of the shares requires the approval of three quarters of the holders of the shares represented or present and voting at a general meeting duly convened in accordance with the Instrument of Incorporation.

The following table shows the share class movement during the financial year ended 31 December 2025 and financial year ended 31 December 2024:

Page 66

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 64

4. Share Capital (continued)

Chimera S&P UAE UCITS ETFFinancial Year1 January 2025to 31 December 2025Financial Year1 January 2024to 31 December 2024Class A Accumulating Shares

Balance at beginning of financial year500,000500,000

Balance at end of financial year500,000500,000

Class D Distributing Shares

Balance at beginning of financial year28,000,00028,000,000

Shares redeemed^(1,000,000)–

Balance at end of financial year27,000,00028,000,000

^ Includes in-kind in-kind redemptions of 1,000,000 shares valued at AED 5,741,000 for Class D Distributing Shares for the financial year.

Chimera S&P Pakistan UCITS ETF Financial Year

1 January 2025to 31 December 2025Financial Year1 January 2024to 31 December 2024Class D Distributing Shares

Balance at beginning of financial year1,000,0001,000,000

Balance at end of financial year1,000,0001,000,000

Chimera JP Morgan UAE Bond UCITS ETF Financial Year

1 January 2025to 31 December 2025Financial Period25 March 2024to 31 December 2024Class D Distributing Shares

Balance at beginning of financial year5,000,000–

Shares issued–6,500,000

Shares redeemed(500,000)(1,500,000)

Balance at end of financial year4,500,0005,000,000

Chimera S&P Japan UCITS ETFFinancial Year1 January 2025to 31 December 2025Financial Period28 May 2024to31 December 2024Class D Distributing Shares

Balance at beginning of financial year3,500,000–

Shares issued^–6,000,000

Shares redeemed^(1,000,000)(2,500,000)

Balance at end of financial year2,500,0003,500,000

^ Includes in-kind subscriptions of 6,000,000 shares valued at JPY 942,000,000 for the prior financial period and in-kind redemptions of 1,000,000 (31 December 2024: 2,500,000) shares valued at JPY 181,002,500 (31 December 2024: JPY 394,853,000) for Class D Distributing Shares for the financial year.

Page 67

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 65

4. Share Capital (continued)

Chimera S&P Germany UCITS ETFFinancial Year1 January 2025to 31 December 2025Financial Period25 September 2024to 31 December 2024Class D Distributiong Shares

Balance at beginning of financial year3,500,000–

Shares issued^500,0003,500,000

Shares redeemed^(1,500,000)–

Balance at end of financial year2,500,0003,500,000

^ Includes in-kind subscriptions of 500,000 (31 December 2024: 3,500,000) shares valued at EUR 544,000 (31 December 2024:

EUR 3,146,500) and in-kind redemptions of 1,500,000 shares valued at EUR 1,535,000 for Class D Distributing Shares for the financial year.

Boreas Solactive Quantum Computing UCITS ETF*Financial Period24 November 2025to 31 December 2025Class B Distributing Shares

Balance at beginning of financial year/period – Shares issued^ 18,900,000

Shares redeemed^ (1,800,000)Balance at end of financial year/period 17,100,000

^ Includes in-kind subscriptions of 450,000 shares valued at USD 236,793 and in-kind redemptions of 1,800,000 shares valued at USD 1,137,541 for Class D Distributing Shares for the financial period.

Boreas S&P AI Data, Power and Infrastructure UCITSETF**Financial Period24 November 2025to 31 December 2025Class B Distributing Shares

Balance at beginning of financial year/period – Shares issued 33,300,000

Shares redeemed (450,000)Balance at end of financial year/period 32,850,000

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

Page 68

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 66

5. Net (Losses)/Gains on Financial Assets at Fair Value Through Profit or Loss Chimera S&P UAE

UCITS ETFChimera S&P PakistanUCITS ETFFinancial Year1 January 2025to 31 December2025AEDFinancial Year1 January 2024to 31 December2024AEDFinancial Year1 January 2025to 31 December2025PKRFinancial Year1 January 2024to 31 December2024PKRNet realised gains/(losses) on sale of

financial assets at FVTPL1,664,529(691,938)71,863,85821,650,053

Net realised (losses)/gains on other currency(4)224–(240)

Net change in unrealised appreciation on

financial assets at FVTPL19,775,19916,244,920257,230,256268,465,023

Other currency gains––1705

Net gains on financial assets at fair value

through profit or loss21,439,72415,553,206329,094,284290,114,841

Chimera JP Morgan UAE BondUCITS ETFChimera S&P JapanUCITS ETFFinancial Year1 January 2025to 31 December2025USDFinancial Period25 March 2024to 31 December2024USDFinancial Year1 January 2025to 31 December2025JPYFinancial Period28 May 2024to 31 December2024JPYNet realised gains/(losses) on sale of

financial assets at FVTPL14,344(9,839)17,293,913(2,808,412)

Net realised gains on other currency–3––

Net change in unrealisedappreciation/(depreciation) on financial

assets at FVTPL134,558(70,270)92,316,67913,852,994

Other currency gains2–––

Net gains/(losses) on financial assets at

fair value through profit or loss148,904(80,106)109,610,59211,044,582

Page 69

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 67

5. Net (Losses)/Gains on Financial Assets at Fair Value Through Profit or Loss (continued) Chimera S&P Germany

UCITS ETFBoreas SolactiveQuantumComputingUCITS ETF*Financial Year1 January 2025to 31 December2025EURFinancial Period25 September2024to 31 December2024EURFinancial Period19 September2025to 31 December2025USDNet realised gains on sale of financial assets

at FVTPL180,9604,379596,490

Net change in unrealisedappreciation/(depreciation) on financial

assets at FVTPL348,955131,121(700,672)

Net gains/(losses) on financial assets at

fair value through profit or loss529,915135,500(104,182)

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

Boreas S&P AIData, Power andInfrastructureUCITS ETF**Financial Period24 November2025to 31 December2025USD

Net realised losses on sale of financial assets at FVTPL (27,969)

Net realised gains on other currency 44,582 Net change in unrealised appreciation on financial assets at FVTPL 212,719

Other currency gains 8

Net gains on financial assets at fair value through profit or loss 229,340

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

Page 70

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 68

6. Cash and Cash Equivalents

Cash and cash equivalents at the financial year ended 31 December 2025 and 31 December 2024 are held at, The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary”).

The Standard & Poor’s long term credit rating of the Depositary was AA- at 31 December 2025 (31 December 2024: AA-).

7. Taxation

Under current law and practice, the ICAV qualifies as an investment undertaking as defined in Section 739B of the Taxes Consolidation Act, 1997, as amended. On that basis, it is not chargeable to Irish tax on its income or gains.

However, Irish tax may arise on the happening of a “chargeable event”. A chargeable event includes any distribution payments to Shareholders, any encashment, redemption, cancellation or transfer of Shares and the holding of Shares at the end of each eight year period beginning with the acquisition of such Shares.

No Irish tax will arise on the Sub-Funds in respect of chargeable events in respect of:

(a) transactions by a Shareholder who is neither Irish resident nor ordinarily resident in Ireland for tax purposes at the time of the chargeable event, provided the appropriate valid declarations, in accordance with the provisions of the Taxes Consolidation Act, 1997, as amended, are held by the Sub-Funds or the Sub-Funds have been authorised by the Irish Revenue to make gross payments in the absence of appropriate declarations; and

(b) transactions by certain exempted Irish resident Shareholders who have provided the relevant Sub-Fund with the necessary signed statutory declarations.

Dividends, interest and capital gains, (if any), received on investments made by the Sub-Funds may be subject to taxes imposed by the country from which the investment income/gains are received, and such taxes may not be recoverable by the Sub-Funds or its Shareholders.

In respect of Chimera S&P Pakistan UCITS ETF, the Sub-Fund is subject to Pakistani capital gains taxes. As at the reporting date, the Sub-Fund has a provision of PKR 74,596,918 for capital gains payable, disclosed within "Tax payable" on the Statement of Financial Position. In the financial year, capital gains tax payments in the amount of PKR 7,886,955 and the capital gains tax provision of PKR 74,596,918 are incorporated within the figure of "Capital gains tax" in the Statement of Comprehensive Income.

8. Expenses

The ICAV shall pay to the Manager out of the Sub-Funds’ assets an annual Management Fee of 1% of equity Sub-Funds' and 0.5% of bond Sub-Fund's daily Net Asset Values; the annual Management Fee for Chimera S&P UAE UCITS ETF reduced from 1% to 0.6% of the daily Net Asset Values and for Chimera JP Morgan UAE Bond UCITS ETF reduced from 0.5% to 0.4% of the daily Net Asset Values, effective 25 July 2025. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register) out of the Management Fee and any reasonable and properly vouched expenses as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV and shall further discharge all fees and expenses related to the Sub-Funds.

Page 71

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025Notes to the Audited Financial Statements (continued)69

8. Expenses (contimued)

The following expenses will be discharged by the Manager out of the Management Fee: fees payable to the Depositary, Administrator, Investment Manager, Global Distributor and Directors and all operational expenses, including but not limited to, expenses and reasonable out of pocket expenses of the Depositary, Administrator, Investment Manager, Global Distributor and Directors, the costs of maintaining the Sub-Funds and any registration of the Funds with any governmental or regulatory authority; the costs of registering a Fund in other jurisdictions or with any stock exchange, filing fees; preparation, printing, and posting of the Prospectus and other prospectuses, sales literature and reports to shareholders, regulatory fees of the CBI and other governmental agencies; insurance premiums; fees and expenses for legal, audit, other professionals and other services; levies incurred in connection with acquiring or disposing of Investments or in connection with creation and redemption transactions including any fees and expenses payable as a result of entering into FDI transactions or arising from investment in collective investment schemes (including, without limitation, any fees, charges, taxes, levies or expenses related to the purchase or sale of an amount of any currency, or the patriation or repatriation of any security or other asset, or related to the execution of portfolio transactions or any creation or redemption transactions); fees and expenses incurred in connection with securities lending; paying for sublicensing fees related to each Fund's Index and any distribution fees or expenses but excluding interest, taxes, brokerage commissions and other expenses connected with execution of portfolio transactions, and extraordinary expenses. Where the above expenses exceed the Management Fees, the Investment Manager will discharge any such expenses out of its own assets.The fees and expenses relating to the establishment and approval of the Sub-Funds, including the fees of the ICAV’s professional advisers, the fees and expenses incurred with respect to registering the shares of the Sub-Funds for sale in various markets, and the expenses associated with the issue of shares, including the costs incurred in connection with the preparation and publication of the Supplement, and all legal and printing costs will be borne by the Investment Manager.

9. Transaction Costs

Transaction costs are incremental costs that are directly attributable to the acquisition, issue or disposal of a financial asset or financial liability. An incremental cost is one that would not have been incurred if the entity had not acquired, issued or disposed of the financial instrument. When a financial asset or financial liability is recognised initially, an entity shall measure it at its fair value through profit or loss plus, transaction costs that are directly attributable to the acquisition or issue of the financial asset or financial liability.

Transaction costs on purchases and sales of equities are borne by the Sub-Funds and included within net gains/(losses) on investments in the Statement of Comprehensive Income. Purchases and sales transaction costs include identifiable brokerage charges, commissions, transaction related taxes and other market charges.

Page 72

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 70

9. Transaction Costs (continued)

Transactions costs incurred on purchases and sales during the financial years ended 31 December 2025 and 31 December 2024 were as follows:

Sub-Fund BaseCurrencyFinancial Year Ended31 December 2025Financial Year Ended31 December 2024

Chimera S&P UAE UCITS ETF AED46,55929,170

Chimera S&P Pakistan UCITS ETF PKR965,023342,023

Chimera JP Morgan UAE Bond UCITS ETF USD - -

Chimera S&P Japan UCITS JPY114,35685,084

Chimera S&P Germany UCITS ETF EUR137195

Boreas Solactive Quantum Computing UCITS ETF* USD 5,019 N/A Boreas S&P AI Data, Power and Infrastructure

UCITS ETF**CHF 145 N/ABoreas S&P AI Data, Power and InfrastructureUCITS ETF** DKK 182 N/ABoreas S&P AI Data, Power and InfrastructureUCITS ETF** EUR 9,182 N/ABoreas S&P AI Data, Power and InfrastructureUCITS ETF**GBP 2,212 N/ABoreas S&P AI Data, Power and InfrastructureUCITS ETF**USD 1,432 N/A

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024.

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024.

10. Related Parties transactions

According to IAS 24 Related Parties, parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions or is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. The following related party relationships and transactions have been identified. The Directors, Manager and the Investment Manager are considered as key management personnel for this purpose.

The Manager is entitled to receive out of the Sub-Funds’ assets an annual Management Fee of 1% of equity Sub-Funds' and 0.5% of bond Sub-Fund's daily Net Asset Values; the annual Management Fee for Chimera S&P UAE UCITS ETF reduced from 1% to 0.6% of the daily Net Asset Values and for Chimera JP Morgan UAE Bond UCITS ETF reduced from 0.5% to 0.4% of the daily Net Asset Values, effective 25 July 2025. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register). The Manager is also entitled to be reimbursed for any reasonable and properly vouched expenses (the “Manager’s Expenses”) as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV.

Total fees earned by the Manager during the financial year ended 31 December 2025 amounted to EUR 68,245 (31 December 2024: EUR 67,746) of which EUR 21,250 was outstanding at 31 December 2025 (31 December 2024: EUR 28,333).

The emoluments of all the Directors who are entitled to remuneration for their services as Directors in respect of any twelve-month accounting period shall not exceed €80,000 or such higher amount as may be approved by the Board of Directors. The Directors are also entitled to be reimbursed for their reasonable out of pocket expenses incurred in discharging their duties as Directors. Such fees and expenses are paid out of the annual management fee paid to the Manager.

Page 73

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025Notes to the Audited Financial Statements (continued)71

10. Related Parties transactions (continued)

Directors’ fees incurred during the financial year ended 31 December 2025 amounted to EUR 40,000 (31 December 2024: EUR 40,000) of which EUR Nil was outstanding at 31 December 2025 (31 December 2024: EUR Nil). Directors' fees were earned by 2 of the Independent Directors. None of the Directors who are employees of the Investment Manager or its related entity earned fees during the financial year ended 31 December 2025 and 31 December 2024.

Related Party Shareholdings

In accordance with IAS 24 Related Party Disclosures, the following transactions with related parties were identified during the year.

As at 31 December 2025, Mr. Sherif Salem, a Director of the Fund, acquired 590 shares in Chimera S&P Pakistan UCITS ETF

– Income (31 December 2024: 590 shares) and 6,795 shares in Chimera JP Morgan UAE Bond UCITS ETF – Income (31 December 2024: 6,795 shares). There were no other shareholdings in the Fund by any Director during the years ended 31

December 2025 and 31 December 2024.

The Investment Manager earned fees for investment management services of AED 1,785,519 during the financial year ended 31

December 2025 (31 December 2024: AED 1,511,158) of which AED 418,326 was outstanding at 31 December 2025 (31

December 2024: AED 468,910). As with the other expenses, the fees are paid out of the annual management fee paid to the Manager.

At 31 December 2025, the ICAV had five Authorised Participants, Arqaam Capital, BHM Capital Financial Services PJSC, EFG Hermes UAE L.L.C., International Securities L.L.C. and HSBC Bank Plc, through which share transactions are conducted on the primary market. International Securities L.L.C is a related party to the Investment Manager.

At 31 December 2025, the 2 Subscriber shares were held on behalf on the ICAV by the Investment Manager.

11. Contingent Liabilities and Commitments

Except for the matters as disclosed in Note 7, there were no other contingent liabilities or commitments as at the financial year ended 31 December 2025 and 31 December 2024.

12. Segregation of Liability

The ICAV is an umbrella fund with segregated liability between Sub-Funds and each Sub-Fund may comprise one or more classes of shares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, establish further Sub- Funds by the issue of one or more separate classes of shares on such terms as the Directors may resolve. The Directors may, from time to time, in accordance with the requirements of the CBI, establish one or more separate classes of shares within each Sub-Fund on such terms as the Directors may resolve.

13. Umbrella Cash Collection Accounts

The CBI published the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) Investor Money Regulations 2015 for Fund Service Providers (the “Investor Money Regulations” or “IMR”) in March 2015 (effective from 1 July 2016). The Management Company, together with the Administrator implemented procedures in relation to the way subscription and redemption monies are channeled to and from the ICAV. These transactions are channeled through an umbrella cash collection account in the name of the ICAV. Pending issue of the shares and/or payment of subscription proceeds to an account in the name of the ICAV or the relevant Sub-Funds, and pending payment of redemption proceeds or distributions, the relevant investor will be an unsecured creditor of the relevant Sub-Fund in respect of amounts paid by or due to it. As at 31 December 2025 and 31

December 2024, there was no IMR related balance included within cash and cash equivalents in the Statement of Financial Position.

Page 74

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 72

14. Net Asset Value Attributable to Holders of Redeemable Participating Shares Chimera S&P UAE UCITS ETF

As at31 December 2025As at31 December 2024As at31 December 2023Total Net Asset ValueClass A Accumulating Shares AED 3,361,992 AED 2,815,871 AED 2,406,435

Class D Distributing Shares AED 153,979,245 AED 138,583,204 AED 123,343,017

Net Asset Value per ShareClass A Accumulating Shares AED 6.724 AED 5.632 AED 4.813Class D Distributing Shares AED 5.703 AED 4.949 AED 4.405Chimera S&P Pakistan UCITS ETFAs at31 December 2025As at31 December 2024As at31 December 2023Total Net Asset Value

Class D Distributing Shares PKR 911,282,190 PKR 658,728,998 PKR 366,562,034 Net Asset Value per Share

Class D Distributing Shares PKR 911.282 PKR 658.729 PKR 366.562 Chimera JP Morgan UAE Bond UCITS ETF

As at31 December 2025As at31 December 2024As at31 December 2023Total Net Asset Value

Class D Distributing Shares USD 4,666,381 USD 5,094,870 USD – Net Asset Value per Share

Class D Distributing Shares USD 1.037 USD 1.019 USD – Chimera S&P Japan UCITS ETF

As at31 December 2025As at31 December 2024As at31 December 2023Total Net Asset Value

Class D Distributing Shares JPY 487,286,378 JPY 560,071,472 JPY – Net Asset Value per Share

Class D Distributing Shares JPY 194.915 JPY 160.020 JPY –

Page 75

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 73

14. Net Asset Value Attributable to Holders of Redeemable Participating Shares (continued) Chimera S&P Germany UCITS ETF

As at31 December 2025As at31 December 2024As at31 December 2023Total Net Asset ValueClass D Distributing Shares EUR 2,806,089 EUR 3,273,531 EUR –Net Asset Value per ShareClass D Distributing Shares EUR 1.122 EUR 0.935 EUR –

Chimera JP Morgan UAE Bond UCITS ETF, Chimera S&P Japan UCITS ETF and Chimera S&P Germany UCITS ETF launched in the prior financial year. Hence, there is no comparative data for 31 December 2023.

Boreas Solactive Quantum Computing UCITS ETF*As at31 December 2025As at31 December 2024As at31 December 2023Total Net Asset Value

Class B Distributing Shares USD 9,230,667 USD – USD – Net Asset Value per Share

Class B Distributing Shares USD 0.540 USD – USD –

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025. Therefore, there are no comparatives as at 31 December 2024 and 31 December 2023.

Boreas S&P AI Data, Power and Infrastructure UCITS ETF**

As at31 December 2025As at31 December 2024As at31 December 2023Total Net Asset Value

Class B Distributing Shares USD 18,470,439 USD – USD – Net Asset Value per Share

Class B Distributing Shares USD 0.562 USD – USD –

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025. Therefore, there are no comparatives as at 31 December 2024 and 31 December 2023.

15. Soft Commissions and Directed Brokerage Arrangements

There were no soft commissions and directed brokerage arrangements entered into by the ICAV and the Sub-Funds during the financial year ended 31 December 2025 and 31 December 2024.

Page 76

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 74

16. Distributions

Chimera S&P UAE UCITS ETFFinancial year ended 31 December 2025

Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating

Share AED

Class D Distributing Shares 30 June 2025 21 July20250.10763,012,800

Class D Distributing Shares 22 December 2025 31 December20250.09642,602,800

5,615,600Financial year ended 31 December 2024

Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating

Share AED

Class D Distributing Shares 14 June 2024 10 July20240.09762,732,800

Class D Distributing Shares 19 December 2024 10 January20250.08192,293,200

5,026,000Chimera S&P Pakistan UCITS ETFFinancial year ended 31 December 2025

Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating

Share PKR

Class D Distributing Shares 13 February 2025 07 March202515.985915,985,900

Class D Distributing Shares 7 August 2025 1 September202516.880916,880,900

32,866,800Financial year ended 31 December 2024

Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating

Share PKR

Class D Distributing Shares 12 July 2024 19 July202428.964328,964,300

28,964,300Chimera JP Morgan UAE Bond UCITS ETFFinancial year ended 31 December 2025

Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating

Share USD

Class D Distributing Shares 03 February 2025 17 February20250.0343171,500

Class D Distributing Shares 01 August 2025 14 August20250.0229114,500

286,000

Page 77

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 75

16. Distributions (continued)

Chimera S&P Japan UCITS ETFFinancial year ended 31 December 2025

Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating

Share JPY

Class D Distributing Shares 30 June 2025 21 July20250.34671,213,450

Class D Distributing Shares 22 December 2025 12 January20261.48303,707,500

4,920,950Chimera S&P Germany UCITS ETFFinancial year ended 31 December 2025

Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating

Share EUR

Class D Distributing Shares 30 June 2025 21 July20250.013834,500

34,500

17. Exchange Rates

The following average exchange rate was used to convert certain expense payments to AED:

Financial year ended31 December 2025Financial year ended31 December 2024

EUR0.2414280.254693

JPY40.744088941.344600

PKR76.53007075.845904

USD0.2722630.272261

18. Efficient Portfolio Management

The Investment Manager may, on behalf of the Sub-Funds and subject to the conditions and within the limits laid down by the Central Bank of Ireland, employ techniques and instruments relating to transferable securities and money market instruments for efficient portfolio management purposes in accordance with the investment strategy of the Sub-Funds.

Transactions for the purposes of efficient portfolio management may be undertaken with a view to achieving the reduction of risk, the reduction of cost, or the generation of additional capital or income for the Sub-Funds with an appropriate level of risk and taking into account the risk profile of each Sub-Fund. Techniques and instruments used for efficient portfolio management purposes may include Investments in financial derivative instruments (“FDI”) including futures, options and swaps, the entry into securities lending transactions, repurchase and/or reverse repurchase agreements. All revenues arising from efficient portfolio management activities, net of direct and indirect operational costs will be retained by the Sub-Funds and recognised in the Statement of Comprehensive Income.

The Sub-Funds did not engage in any efficient portfolio management activities during the financial year ended 31 December 2025 and 31 December 2024.

Page 78

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 Notes to the Audited Financial Statements (continued) 76

19. Auditor’s remuneration

Financial year ended31 December 2025EURFinancial year ended31 December 2024EURStatutory audit 73,000 47,00073,000 47,000

20. Significant Events during the Financial Year

Effective 3 June 2025, the addresses of the Depositary and Administrator of the ICAV were changed, as detailed in the "Directors and Other Information" section of the annual report and accounts.

The Total Expense Ratios (TERs) for the Chimera JP Morgan UAE Bond ETF Income Share Class and the Chimera S&P UAE UCITS ETF Accumulating and Income Share Classes were reduced from 50 to 40 basis points and 100 to 60 basis points, respectively, effective 25 July 2025.

HSBC Bank UK was appointed as additional Authorised Participant for the ICAV, effective 9 July 2025.

Effective 12 September 2025, an updated Prospectus for the ICAV was approved by the CBI and issued.

Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025 with listing date of 22 September 2025, on Abu Dhabi Securities Exchange.

Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025 with listing date of 25

November 2025, on Abu Dhabi Securities Exchange.

There have been no other significant events that require disclosure in the financial statements.

21. Subsequent Events after the Financial Year End

Boreas S&P AI Data, Power and Infrastructure UCITS ETF established a second listing on Xetra exchange with an effective date of 14 January 2026.

Boreas S&P Absolute Luxury UCITS ETF was launched on 26 January 2026 with a listing date of 27 January 2026, on Abu Dhabi Securities Exchange and Xetra Exchange.

Boreas Solactive Quantum Computing UCITS ETF established a second listing on Xetra exchange with an effective date of 24

February 2026.

Subsequent to the reporting date, geopolitical tensions in the Middle East have escalated following a regional conflict. As at the date of approval of these financial statements, the fund manager is actively monitoring the situation. The evolving geopolitical conditions present heightened risks related to regional security, however, as of the reporting date, no disruptions to operations have been identified by the fund manager. Given the rapidly changing circumstances, it is currently not possible to reliably estimate any potential financial impact. Management will continue to closely monitor the situation and assess any implications for the ICAV's operations, financial position, and financial performance.

Subsequent to 31 December 2025 and prior to the authorization of these financial statements for issue, the Fund realized capital gains and received dividend income that may be relevant in assessing potential exposure to super tax under Section 4C of the Pakistan Income Tax Ordinance, 2001 (Super Profits Tax) for the tax year ending 30 June 2026. This event relates to conditions arising after the reporting period and, accordingly, no adjustment has been made to the amounts recognized in these financial statements for the year ended 31 December 2025. Management is preparing a preliminary assessment of the potential exposure; however, the ultimate outcome will depend on the Fund’s income for the full tax year ending 30 June 2026, including the effect of any realized losses in the remainder of that tax year.

There have been no other significant subsequent events after the financial year end that require disclosure in the financial statements.

Page 79

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025Notes to the Audited Financial Statements (continued)77

22. Valuation Point

S&P Germary UCITS ETF, S&P Japan UCITS ETF and Boreas S&P AI Data, Power and Infrastructure UCITS ETF were subject to a fund holiday on 31 December 2025. Hence, the effective valuation point and prices used for the valuation of investments was 30 December 2025, being the last business day in the financial period for the relevant markets.

23. Whistleblowing Policy

The ICAV has adopted a whistleblowing policy pursuant to the Protected Disclosures Act 2014, as amended, which gives legal protection to workers, which includes Directors and Shareholders, who make disclosures, including protections against dismissal or being penalised by the ICAV. Further details are available in the policy, which is available on request from the ICAV.

24. Approval of Annual Report and Audited Financial Statements

The annual report and audited financial statements were approved by the Directors on 22 April 2026.

Page 80

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 78

Schedule of InvestmentsAs at 31 December 2025Chimera S&P UAE UCITS ETF

Security Description Nominal Fair Value AED

% ofNet Assets

Transferable securities admitted to an official stock exchange Equities 99.88% (31 December 2024: 99.83%)

United Arab Emirates 99.88% (31 December 2024: 99.83%)

Abu Dhabi Commercial Bank PJSC803,32911,487,6057.30

Abu Dhabi Islamic Bank PJSC368,7607,655,4584.87

Abu Dhabi National Energy Co PJSC856,1652,885,2761.83

Abu Dhabi National Oil Co for Distribution PJSC729,7522,846,0331.81

ADNOC Drilling Co PJSC649,7973,469,9162.21

Adnoc Gas Plc1,753,3426,224,3643.96

ADNOC Logistics & Services349,4012,068,4541.31

Air Arabia PJSC580,4222,704,7661.72

Aldar Properties PJSC957,9588,334,2355.30

Americana Restaurants International Plc - Foreign Co710,2431,150,5940.73

Amlak Finance PJSC152,296255,8570.16

Borouge Plc747,1101,964,8991.25

Dubai Electricity & Water Authority PJSC2,284,4426,327,9044.02

Dubai Islamic Bank PJSC735,1586,814,9154.33

Emaar Development PJSC213,2153,230,2072.05

Emaar Properties PJSC1,570,46622,065,04714.02

Emirates NBD Bank PJSC625,29617,414,49411.07

Emirates Telecommunications Group Co PJSC882,99316,194,09210.29

Fertiglobe plc288,206717,6330.46

First Abu Dhabi Bank PJSC1,121,71219,562,65712.43

Lulu Retail Holdings Plc770,201878,0290.56

Modon Holding PSC772,0092,593,9501.65

Parkin Co PJSC185,9901,058,2830.67

Presight AI Holding Plc209,538687,2850.44

Salik Co PJSC475,9253,022,1241.92

Sharjah Islamic Bank328,5211,024,9850.65

Space42 Plc248,558390,2360.25

Talabat Holding Plc1,157,6981,088,2360.69

Two Point Zero Group PJSC995,0012,596,9531.65

Union Properties PJSC522,438438,3250.28

Total United Arab Emirates157,152,81299.88

Page 81

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 79

Chimera S&P UAE UCITS ETF (continued)Security Description Nominal Fair ValueAED% ofNet Assets

Transferable securities admitted to an official stock exchange (continued) Equities 99.88% (31 December 2024: 99.83%) (continued)

United Arab Emirates 99.88% (31 December 2024: 99.83%) (continued)

Total Equities157,152,81299.88

Total Transferable securities admitted to an official stock exchange157,152,81299.88

Total Financial assets at fair value through profit or loss157,152,81299.88

Cash and cash equivalents446,9960.28

Net other liabilities(258,571)(0.16)

Total Net assets attributable to holders of redeemable participating

shares157,341,237100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 99.72

Cash and cash equivalents 0.28Total Assets 100.00

Page 82

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 80

Schedule of InvestmentsAs at 31 December 2025 (continued)Chimera S&P Pakistan UCITS ETF

Security Description Nominal Fair Value PKR

% ofNet Assets

Transferable securities admitted to an official stock exchange Equities 105.21% (31 December 2024: 96.89%)

Pakistan 105.21% (31 December 2024: 96.89%)

Engro Fertilizers Ltd202,70845,882,9565.03

Fauji Cement Co Ltd322,96718,070,0041.98

Fauji Fertilizer Co Ltd274,958162,420,44017.82

Habib Bank Ltd217,61870,379,8377.72

Hub Power Co Ltd/The362,50780,251,8008.81

Lucky Cement Ltd151,63572,020,5607.90

Mari Energies Ltd82,84759,309,3396.51

Meezan Bank Ltd142,88163,493,4596.97

National Bank of Pakistan183,50744,441,7254.88

Oil & Gas Development Co Ltd222,58462,566,1366.87

Pakistan Petroleum Ltd234,69555,282,4076.07

Pakistan State Oil Co Ltd119,86256,833,7666.24

SUI Northern Gas Pipeline149,43417,860,3521.96

TRG Pakistan94,4896,884,4680.75

United Bank Ltd/Pakistan336,963143,071,12015.70

Total Pakistan958,768,369105.21

Total Equities958,768,369105.21

Total Transferable securities admitted to an official stock exchange958,768,369105.21

Total Financial assets at fair value through profit or loss958,768,369105.21

Cash and cash equivalents29,480,0533.24

Net other liabilities(76,966,232)(8.45)

Total Net assets attributable to holders of redeemable participating

shares911,282,190100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 97.02

Cash and cash equivalents 2.98Total Assets 100.00

Page 83

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 81

Schedule of InvestmentsAs at 31 December 2025 (continued)Chimera JP Morgan UAE Bond UCITS ETFSecurity Description Nominal Fair ValueUSD% ofNet AssetsTransferable securities admitted to an official stock exchangeCorporate Bonds 84.61% (31 December 2024: 83.90%)Cayman Islands 46.25% (31 December 2024: 21.51%)

Aldar Sukuk No 2 Ltd 3.88% 22/10/2029200,000195,0684.18

BOS Funding Ltd 'EMTN' 7.00% 14/03/2028200,000207,8704.46

DIB Sukuk Ltd 'EMTN' 4.57% 19/11/2030225,000224,0934.81

DP World Crescent Ltd 'EMTN' 3.88% 18/07/2029272,000265,6145.69

EI Sukuk Co Ltd 5.43% 28/05/2029200,000205,5004.40

Emaar Sukuk Ltd 'EMTN' 3.88% 17/09/2029203,000199,3214.27

Esic Sukuk Ltd 5.83% 14/02/2029215,000220,9264.74

Fab Sukuk Co Ltd 5.15% 16/01/2030200,000206,4464.42

MAF Sukuk Ltd 4.64% 14/05/2029229,000229,6504.92

SIB Sukuk Co III Ltd 5.20% 26/02/2030200,000203,5184.36

Total Cayman Islands2,158,00646.25

Jersey 3.76% (31 December 2024: 3.31%)

Galaxy Pipeline Assets Bidco Ltd 'REGS' 2.94% 30/09/2040206,198175,4583.76

Total Jersey175,4583.76

United Arab Emirates 30.44% (31 December 2024: 59.08%)

Abu Dhabi Commercial Bank PJSC 'GMTN' 4.50% 14/09/2027200,000200,7014.30

Abu Dhabi Crude Oil Pipeline LLC 'REGS' 4.60% 02/11/2047207,000192,3714.12

Abu Dhabi Developmental Holding Co PJSC 'REGS' 4.38% 02/10/2031245,000244,1115.23

Abu Dhabi National Energy Co PJSC 'REGS' 6.50% 27/10/2036200,000227,9904.89

Adnoc Murban Rsc Ltd 'REGS' 5.13% 11/09/2054200,000188,0804.03

MDGH GMTN RSC Ltd 'GMTN' 5.29% 04/06/2034200,000208,7824.48

MDGH GMTN RSC Ltd 'GMTN' 3.95% 21/05/2050200,000158,3163.39

Total United Arab Emirates1,420,35130.44

United States 4.16% (31 December 2024: –)

DAE Funding LLC 'REGS' 3.38% 20/03/2028200,000194,3284.16

Total United States194,3284.16

Total Corporate Bonds3,948,14384.61

Government Bonds 12.86% (31 December 2024: 13.72%) United Arab Emirates 12.86% (31 December 2024: 13.72%)

Abu Dhabi Government International Bond 'REGS' 5.00% 30/04/2034212,000222,9454.78

Abu Dhabi Government International Bond 'REGS' 3.13% 30/09/2049236,000168,5043.61

UAE International Government Bond 'REGS' 4.86% 02/07/2034201,000208,6384.47

Total United Arab Emirates600,08712.86

Total Government Bonds600,08712.86

Page 84

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 82

Chimera JP Morgan UAE Bond UCITS ETF (continued)Security Description Nominal Fair ValueUSD% ofNet Assets

Transferable securities admitted to an official stock exchange (continued) Mutual Funds 1.48% (31 December 2024: 1.28%)

Ireland 1.48% (31 December 2024: 1.28%)

Goldman Sachs plc - US$ Treasury Liquid Reserves Fund0.00%64,33569,0961.48

Total Ireland69,0961.48

Total Mutual Funds69,0961.48

Total Transferable securities admitted to an official stock exchange4,617,32698.95

Total Financial assets at fair value through profit or loss4,617,32698.95

Cash and cash equivalents260.00

Net other assets49,0291.05

Total Net assets attributable to holders of redeemable participating

shares4,666,381100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 98.84

Cash and cash equivalents 0.00Other assets 1.16Total Assets 100.00

Page 85

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 83

Schedule of InvestmentsAs at 31 December 2025 (continued)Chimera S&P Japan UCITS ETF

Security Description Nominal Fair Value JPY

% ofNet AssetsTransferable securities admitted to an official stock exchangeEquities 99.74% (31 December 2024: 99.76%)Japan 99.74% (31 December 2024: 99.76%)

Advantest Corp1,16022,776,6004.67

Disco Corp1436,888,3101.41

Fast Retailing Co Ltd31818,106,9203.72

Fujikura Ltd4177,272,4801.49

Furukawa Electric Co Ltd1041,041,0400.21

Hitachi Ltd6,94634,049,2926.99

IHI Corp1,6544,555,9430.94

JX Advanced Metals Corp8001,568,0000.32

Kawasaki Heavy Industries Ltd2422,511,9600.52

Keyence Corp30217,117,3603.51

Kioxia Holdings Corp2782,900,9300.60

Lasertec Corp (Units)1173,468,4650.71

Metaplanet Inc1,590643,9500.13

Mitsubishi Corp6,14122,021,6264.52

Mitsubishi Heavy Industries Ltd5,06819,461,1203.99

Mitsubishi UFJ Financial Group Inc18,28245,577,0269.35

Mizuho Financial Group Inc3,78821,591,6004.43

Nintendo Co Ltd1,76918,742,5553.85

Recruit Holdings Co Ltd2,36720,940,8494.30

Ryohin Keikaku Co Ltd8362,325,7520.48

Sanrio Co Ltd3111,529,1870.31

Shin-Etsu Chemical Co Ltd3,03314,779,8093.03

Socionext Inc300656,8500.13

SoftBank Group Corp5,88825,907,2005.32

Sony Group Corp9,30937,459,4167.69

Sumitomo Mitsui Financial Group Inc5,83929,434,3996.04

Tokio Marine Holdings Inc2,92817,032,1763.50

Tokyo Electric Power Co Holdings Inc1,200788,7600.16

Tokyo Electron Ltd71424,504,4805.03

Toyota Motor Corp17,98560,357,76112.39

Total Japan486,011,81699.74

Page 86

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 84

Chimera S&P Japan UCITS ETF (continued)Security Description Nominal Fair ValueJPY% ofNet Assets

Transferable securities admitted to an official stock exchange (continued) Equities 99.74% (31 December 2024: 99.76%) (continued)

Japan 99.74% (31 December 2024: 99.76%) (continued)

Total Equities486,011,81699.74

Total Transferable securities admitted to an official stock exchange486,011,81699.74

Total Financial assets at fair value through profit or loss486,011,81699.74

Cash and cash equivalents6,577,9721.35

Net other liabilities(5,303,410)(1.09)

Total Net assets attributable to holders of redeemable participating

shares487,286,378100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 98.66

Cash and cash equivalents 1.34Total Assets 100.00

Page 87

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 85

Schedule of InvestmentsAs at 31 December 2025 (continued)Chimera S&P Germany UCITS ETF

Security Description Nominal Fair Value EUR

% ofNet AssetsTransferable securities admitted to an official stock exchangeEquities 99.76% (31 December 2024: 99.86%)Germany 99.76% (31 December 2024: 99.86%)

adidas AG33857,1392.04

Allianz SE721281,55010.03

BASF SE1,67674,4652.65

Bayer AG1,83567,9132.42

Bayerische Motoren Werke AG49546,1041.64

Beiersdorf AG16815,7380.56

Commerzbank AG1,85466,9292.39

Daimler Truck Holding AG90133,6251.20

Deutsche Bank AG3,661121,2164.32

Deutsche Boerse AG35479,1902.82

Deutsche Lufthansa AG1,1009,2470.33

Deutsche Post AG1,80384,2543.00

Deutsche Telekom AG6,414177,4116.32

Dr Ing hc F Porsche AG - Preference '144A'2059,3520.33

E.ON SE4,16967,2252.40

Fresenius SE & Co KGaA77237,8131.35

Heidelberg Materials AG24153,7431.92

Hensoldt AG1158,4410.30

Infineon Technologies AG2,45392,5523.30

Mercedes-Benz Group AG1,35781,5152.90

Merck KGaA24830,4051.08

Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen245137,7394.91

RENK Group AG1427,6140.27

Rheinmetall AG86134,2464.78

RWE AG1,25856,9372.03

SAP SE1,905396,90714.14

Siemens AG1,375328,83111.72

Siemens Energy AG1,351162,6605.80

Volkswagen AG - Preference38740,0741.43

Vonovia SE1,57538,6511.38

Total Germany2,799,48699.76

Page 88

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 86

Chimera S&P Germany UCITS ETF (continued)Security Description Nominal Fair ValueEUR% ofNet Assets

Transferable securities admitted to an official stock exchange (continued) Equities 99.76% (31 December 2024: 99.86%) (continued)

Germany 99.76% (31 December 2024: 99.86%) (continued)

Total Equities2,799,48699.76

Total Transferable securities admitted to an official stock exchange2,799,48699.76

Total Financial assets at fair value through profit or loss2,799,48699.76

Cash and cash equivalents13,9170.50

Net other liabilities(7,314)(0.26)

Total Net assets attributable to holders of redeemable participating

shares2,806,089100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 99.51

Cash and cash equivalents 0.49Total Assets 100.00

Page 89

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 87

Schedule of InvestmentsAs at 31 December 2025 (continued)Boreas Solactive Quantum Computing UCITS ETF*Security Description Nominal Fair ValueUSD% ofNet Assets

Transferable securities admitted to an official stock exchange Equities 99.74% (31 December 2024: –)

British Virgin Islands 6.59% (31 December 2024: –)

SEALSQ Corp160,933608,3276.59

Total British Virgin Islands608,3276.59

United States 93.15% (31 December 2024: –)

Aeluma Inc11,693200,7692.18

Alphabet Inc - Class A2,732855,1169.26

Amazon.com Inc884204,0452.21

Applied Digital Corp4,754116,5681.26

ASP Isotopes Inc47,384253,5042.75

Booz Allen Hamilton Holding Corp - Class A3,872326,6423.54

D-Wave Quantum Inc23,008601,6596.52

FormFactor Inc8,749488,0195.29

Fortinet Inc3,072243,9472.64

Honeywell International Inc2,706527,9145.72

Intel Corp1,77465,4610.71

International Business Machines Corp2,193649,5887.04

IonQ Inc10,605475,8465.16

Marvell Technology Inc3,231274,5702.97

Microchip Technology Inc6,947442,6634.80

Micron Technology Inc1,182337,3553.65

Microsoft Corp695336,1163.64

NVIDIA Corp2,826527,0495.71

Onto Innovation Inc1,201189,5902.05

QUALCOMM Inc19833,8680.37

Quantum Computing Inc35,306362,2403.92

Rigetti Computing Inc17,777393,7614.27

SkyWater Technology Inc30,953562,1066.09

Solstice Advanced Materials Inc67332,6940.35

Veeco Instruments Inc3,40797,3721.05

Total United States8,598,46293.15

Page 90

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 88

Boreas Solactive Quantum Computing UCITS ETF* (continued) Security Description Nominal Fair Value

USD% ofNet Assets

Transferable securities admitted to an official stock exchange (continued) Equities 99.74% (31 December 2024: –) (continued)

United States 93.15% (31 December 2024: –) (continued)

Total Equities9,206,78999.74

Total Transferable securities admitted to an official stock exchange9,206,78999.74

Total Financial assets at fair value through profit or loss9,206,78999.74

Cash and cash equivalents37,5630.41

Net other liabilities(13,685)(0.15)

Total Net assets attributable to holders of redeemable participating

shares9,230,667100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 99.59 Cash and cash equivalents 0.41

Total Assets 100.00

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025.

Page 91

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 89

Schedule of InvestmentsAs at 31 December 2025 (continued)

Boreas S&P AI Data, Power and Infrastructure UCITS ETF** Security Description Nominal Fair Value

USD% ofNet AssetsTransferable securities admitted to an official stock exchangeEquities 99.73% (31 December 2024: –)Cayman Islands 0.07% (31 December 2024: –)

Vnet Group Inc ADR1,41912,0330.07

Total Cayman Islands12,0330.07

Denmark 0.76% (31 December 2024: –)

NKT A/S48260,6000.33

Orsted AS '144A'4,14779,8890.43

Total Denmark140,4890.76

France 9.09% (31 December 2024: –)

Engie SA15,616411,4922.23

Legrand SA2,189328,3041.77

Nexans SA32247,9330.26

Schneider Electric SE3,214891,6944.83

Total France1,679,4239.09

Germany 6.70% (31 December 2024: –)

E.ON SE16,940321,1911.74

Siemens AG3,261917,0034.96

Total Germany1,238,1946.70

Ireland 4.29% (31 December 2024: –)

Eaton Corp Plc2,467791,5624.29

Total Ireland791,5624.29

Italy 4.79% (31 December 2024: –)

Enel SpA58,994615,7783.33

Prysmian SpA2,657269,8701.46

Total Italy885,6484.79

Spain 6.28% (31 December 2024: –)

Endesa SA2,847102,8730.56

Iberdrola SA48,7051,056,9085.72

Total Spain1,159,7816.28

Switzerland 5.12% (31 December 2024: –)

ABB Ltd12,623945,0885.12

Total Switzerland945,0885.12

Page 92

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 90

Boreas S&P AI Data, Power and Infrastructure UCITS ETF** (continued) Security Description Nominal Fair Value

USD% ofNet Assets

Transferable securities admitted to an official stock exchange (continued) Equities 99.73% (31 December 2024: –) (continued)

United Kingdom 3.17% (31 December 2024: –)

National Grid Plc37,880585,6783.17

Total United Kingdom585,6783.17

United States 59.46% (31 December 2024: –)

Alphabet Inc3,7861,190,8866.45

Amazon.com Inc4,127959,6515.20

Broadcom Inc2,690941,0975.10

Constellation Energy Corp2,385851,7314.61

Digital Realty Trust Inc (REIT)2,855446,4942.42

Dominion Energy Inc6,516384,8352.08

Emerson Electric Co4,698635,5933.44

Entergy Corp3,408318,2051.72

Equinix Inc (REIT)872671,1873.63

Exelon Corp7,711338,6671.83

Fastly Inc1,24212,5940.07

Generac Holdings Inc52672,5140.39

Microsoft Corp1,771863,3274.67

NextEra Energy Inc11,059890,5814.82

Oracle Corp3,220635,0163.44

Public Service Enterprise Group Inc3,811308,3481.67

Quanta Services Inc1,327569,0313.08

Rockwell Automation Inc939369,6662.00

Vertiv Holdings Co - Class A3,188523,9162.84

Total United States10,983,33959.46

Total Equities18,421,23599.73

Total Transferable securities admitted to an official stock exchange18,421,23599.73

Total Financial assets at fair value through profit or loss18,421,23599.73

Cash and cash equivalents52,8170.29

Net other liabilities(3,613)(0.02)

Total Net assets attributable to holders of redeemable participating

shares18,470,439100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 99.69 Cash and cash equivalents 0.29

Other assets 0.02Total Assets 100.00

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025.

Page 93

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 91

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P UAE UCITS ETFMajor Purchases<Security Description Nominal CostAED

Abu Dhabi National Energy Co PJSC2,026,6187,065,122

Air Arabia PJSC580,4222,814,345

Borouge PLC805,7121,990,631

Emaar Properties PJSC122,5271,613,396

Talabat Holding PLC1,199,7121,545,826

Abu Dhabi Commercial Bank PJSC115,9301,473,740

First Abu Dhabi Bank PJSC85,9461,277,685

Emirates Telecommunications Group Co PJSC68,9791,185,788

Lulu Retail Holdings PLC865,7821,178,091

Emirates NBD Bank PJSC49,7411,115,047

Sharjah Islamic Bank328,5211,018,950

Aldar Properties PJSC69,171573,306

Space42 PLC257,579487,080

Abu Dhabi Islamic Bank PJSC26,170465,478

Two Point Zero Group PJSC164,267453,346

Union Properties PJSC541,399448,559

Dubai Electricity & Water Authority PJSC140,021377,327

Dubai Islamic Bank PJSC45,061362,294

Adnoc Gas PLC100,421326,369

Deyaar Development PJSC294,423274,615

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 94

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 92

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P UAE UCITS ETFMajor Sales<Security Description Nominal ProceedsAED

Abu Dhabi National Energy Co PJSC2,076,9597,211,273

Emaar Properties PJSC214,8672,869,892

First Abu Dhabi Bank PJSC151,8592,426,030

Emirates Telecommunications Group Co PJSC120,8922,172,155

Emirates NBD Bank PJSC86,5072,080,327

Pure Health Holding PJSC713,1051,848,225

Adnoc Gas PLC409,7851,389,260

Abu Dhabi Commercial Bank PJSC99,5001,304,885

Phoenix Group PLC861,5841,231,418

NMDC Group PJSC58,9811,200,968

Aldar Properties PJSC125,4981,096,670

Abu Dhabi Islamic Bank PJSC47,852997,771

Dubai Islamic Bank PJSC88,287802,112

Apex Investment Co PSC190,985784,536

Dubai Electricity & Water Authority PJSC274,342743,078

Gulf Navigation Holding PJSC113,238595,921

Modon Holding PSC140,292476,334

Ajman Bank PJSC300,538467,979

ADNOC Drilling Co PJSC78,965437,094

Salik Co PJSC57,155342,363

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 95

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 93

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P Pakistan UCITS ETFAll Purchases<Security Description Nominal CostPKR

Pakistan Oilfields Ltd47,05329,522,473

Fauji Fertilizer Co Ltd59,78723,532,595

National Bank of Pakistan187,31519,849,906

SUI Northern Gas Pipeline152,05917,312,562

United Bank Ltd/Pakistan44,47117,224,780

Pakistan State Oil Co Ltd39,37716,523,067

Fauji Cement Co Ltd328,64015,376,863

Hub Power Co Ltd/The62,9669,432,239

Oil & Gas Development Co Ltd31,4077,166,586

Engro Fertilizers Ltd30,8236,559,009

Pakistan Petroleum Ltd33,4046,398,272

Meezan Bank Ltd22,7406,325,768

Lucky Cement Ltd6,6174,123,304

Mari Energies Ltd5,8844,011,616

Habib Bank Ltd14,9813,154,497

MCB Bank Ltd4,2771,228,711

Systems Ltd1,291777,425

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 96

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 94

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P Pakistan UCITS ETFAll Sales<Security Description Nominal ProceedsPKR

Engro Corp Ltd/Pakistan89,48543,282,222

MCB Bank Ltd149,69241,962,080

Systems Ltd60,90734,956,357

Pakistan Oilfields Ltd47,05325,224,301

Lucky Cement Ltd14,83510,517,194

United Bank Ltd/Pakistan22,0667,157,878

Fauji Fertilizer Co Ltd8,9905,077,311

Habib Bank Ltd23,5084,718,711

Hub Power Co Ltd/The22,8794,006,281

Mari Energies Ltd5,8603,866,379

Meezan Bank Ltd9,7363,520,912

Pakistan State Oil Co Ltd8,1423,288,741

Oil & Gas Development Co Ltd11,8052,753,076

Engro Fertilizers Ltd12,9722,520,127

Pakistan Petroleum Ltd12,7352,392,241

National Bank of Pakistan3,808903,569

SUI Northern Gas Pipeline2,625301,631

Fauji Cement Co Ltd5,673252,995

TRG Pakistan4,064229,711

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 97

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 95

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera JP Morgan UAE Bond UCITS ETFAll Purchases<Security Description Nominal CostUSD

Goldman Sachs plc - US$ Treasury Liquid Reserves Fund475,688475,688

DP World Crescent Ltd 'EMTN' 3.75% 30/01/2030350,000333,449

DP World Crescent Ltd 'EMTN' 3.88% 18/07/2029272,000264,147

Abu Dhabi Developmental Holding Co PJSC 'REGS' 4.38% 02/10/2031245,000236,266

DIB Sukuk Ltd 'EMTN' 4.57% 19/11/2030225,000224,426

EI Sukuk Co Ltd 2.08% 02/11/2026229,000220,740

EI Sukuk Co Ltd 5.43% 28/05/2029200,000206,642

SIB Sukuk Co III Ltd 5.2% 26/02/2030200,000204,600

Fab Sukuk Co Ltd 'EMTN' 5.15% 16/01/2030200,000203,550

DIB Sukuk Ltd 'EMTN' 5.24% 04/03/2029200,000202,500

MDGH GMTN RSC Ltd 'REGS' 5.29% 04/06/2034200,000202,302

Emaar Sukuk Ltd 'EMTN' 3.64% 15/09/2026202,000199,198

Emaar Sukuk Ltd 'EMTN' 3.88% 17/09/2029203,000197,074

Aldar Sukuk No 2 Ltd 3.88% 22/10/2029200,000196,072

DAE Funding LLC 'REGS' 3.38% 20/03/2028200,000193,750

Adnoc Murban Rsc Ltd 'REGS' 5.13% 11/09/2054200,000185,480

UAE INTERNATIONAL GOVERNMENT BOND 'REGS' 2.88% 19/10/2041200,000149,090

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 98

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 96

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera JP Morgan UAE Bond UCITS ETFMajor Sales<Security Description Nominal ProceedsUSD

Goldman Sachs plc - US$ Treasury Liquid Reserves Fund471,668471,668

Adnoc Murban Rsc Ltd 'REGS' 4.25% 11/09/2029360,000351,943

DP World Crescent Ltd 'EMTN' 3.75% 30/01/2030350,000335,038

Abu Dhabi Ports Co PJSC 'REGS' 2.50% 06/05/2031300,000262,317

Aldar Investment Properties Sukuk Ltd 4.88% 24/05/2033246,000247,875

DAE Sukuk Difc Ltd 'REGS' 3.75% 15/02/2026248,000245,210

Abu Dhabi Developmental Holding Co PJSC 'REGS' 5.38% 08/05/2029239,000242,492

Commercial Bank of Dubai PSC 'GMTN' 5.32% 14/06/2028230,000236,065

EI Sukuk Co Ltd 'EMTN' 2.08% 02/11/2026229,000223,722

First Abu Dhabi Bank PJSC 'EMTN' 5% 28/02/2029205,000210,551

Adib Sukuk Co II Ltd 5.70% 15/11/2028204,000210,489

Emirates NBD Bank PJSC 5.63% 21/10/2027203,000208,583

DIB Sukuk Ltd 'EMTN' 5.24% 04/03/2029200,000205,202

MDGH GMTN RSC Ltd 'GMTN' 2.5% 21/05/2026206,000201,905

Emaar Sukuk Ltd 'EMTN' 3.64% 15/09/2026202,000199,223

DP World PLC 5.63% 25/09/2048201,000191,513

UAE INTERNATIONAL GOVERNMENT BOND 'REGS' 2.88% 19/10/2041200,000154,148

DP World PLC 6.85% 02/07/2037130,000140,179

UAE INTERNATIONAL GOVERNMENT BOND 'REGS' 3.25% 19/10/2061201,000130,037

Galaxy Pipeline Assets Bidco Ltd 'REGS' 2.94% 30/09/20407,9407,940

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 99

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 97

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P Japan UCITS ETFMajor Purchases<Security Description Nominal CostJPY

Tokio Marine Holdings Inc4,05124,284,514

Toyota Motor Corp1,8165,075,607

Mitsubishi UFJ Financial Group Inc1,9934,305,600

Sony Group Corp1,0073,907,086

Hitachi Ltd7633,284,604

Ryohin Keikaku Co Ltd1,0003,052,916

Sanrio Co Ltd4323,039,613

Kioxia Holdings Corp2782,597,299

Nintendo Co Ltd1902,336,126

Mitsubishi Corp7052,314,574

Sumitomo Mitsui Financial Group Inc5122,102,992

Tokyo Electron Ltd772,070,863

Fast Retailing Co Ltd391,913,839

Mitsubishi Heavy Industries Ltd5091,859,524

Keyence Corp321,793,296

Nissan Motor Co Ltd4,1621,762,580

Advantest Corp1251,733,017

Shin-Etsu Chemical Co Ltd3511,611,374

Mizuho Financial Group Inc3421,608,822

JX Advanced Metals Corp8001,378,013

Recruit Holdings Co Ltd1351,149,868

Furukawa Electric Co Ltd1251,123,837

Metaplanet Inc1,8001,074,921

SoftBank Group Corp91921,996

Renesas Electronics Corp500883,015

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 100

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 98

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P Japan UCITS ETFMajor Sales<Security Description Nominal ProceedsJPY

Toyota Motor Corp8,67925,344,054

Mitsubishi UFJ Financial Group Inc8,59519,830,292

Sony Group Corp4,29017,970,643

Mitsui & Co Ltd5,99617,521,610

Honda Motor Co Ltd10,16516,138,539

Hitachi Ltd3,16912,663,858

SoftBank Group Corp71112,439,334

Sumitomo Mitsui Financial Group Inc2,58210,662,109

Nintendo Co Ltd77810,187,168

NTT Inc63,83610,041,811

Mitsubishi Corp2,6779,132,045

Recruit Holdings Co Ltd1,0968,881,140

Mitsubishi Heavy Industries Ltd2,2008,212,150

Mizuho Financial Group Inc1,6417,987,009

Tokyo Electron Ltd3087,641,770

Renesas Electronics Corp3,7187,333,741

Keyence Corp1297,313,289

Tokio Marine Holdings Inc1,1237,157,721

Advantest Corp4997,007,271

Fast Retailing Co Ltd1386,392,680

Shin-Etsu Chemical Co Ltd1,3286,124,835

Nippon Yusen KK9235,039,075

Mitsui OSK Lines Ltd7453,564,170

Kawasaki Kisen Kaisha Ltd1,3352,896,255

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 101

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 99

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P Germany UCITS ETFMajor Purchases<Security Description Nominal CostEUR

SAP SE43098,712

Siemens AG30468,318

Allianz SE15755,939

Heidelberg Materials AG30454,070

Siemens Energy AG51852,558

Deutsche Telekom AG1,49943,566

Rheinmetall AG2141,343

Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen5328,965

Deutsche Bank AG79023,433

Mercedes-Benz Group AG31917,125

Deutsche Post AG44416,897

Infineon Technologies AG49216,256

adidas AG8916,082

Deutsche Boerse AG7116,067

BASF SE33714,353

Commerzbank AG44514,206

E.ON SE83713,396

Hensoldt AG13813,387

RENK Group AG17012,344

Volkswagen AG11410,660

Bayer AG37010,255

RWE AG2539,558

Bayerische Motoren Werke AG1008,556

Fresenius SE & Co KGaA1838,413

Vonovia SE3158,275

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 102

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 100

Statement of Portfolio Changes for the financial year ended 31 December 2025 (Unaudited) (continued)

Chimera S&P Germany UCITS ETFAll Sales<Security Description Nominal ProceedsEUR

SAP SE1,229302,693

Siemens AG922195,573

Allianz SE474154,479

Deutsche Telekom AG4,337131,116

Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen16385,948

Rheinmetall AG5256,868

Mercedes-Benz Group AG1,02356,782

Deutsche Bank AG2,46653,822

Infineon Technologies AG1,53351,562

Deutsche Boerse AG22150,842

Siemens Energy AG68549,977

BASF SE1,04945,985

adidas AG19443,554

Deutsche Post AG1,11340,143

E.ON SE2,67535,151

Symrise AG35533,254

Covestro AG50830,302

Commerzbank AG1,25329,123

Bayerische Motoren Werke AG35028,460

Bayer AG1,16327,231

Vonovia SE94127,150

RWE AG80626,752

Daimler Truck Holding AG60922,789

Volkswagen AG21819,895

Merck KGaA14719,686

Fresenius SE & Co KGaA49619,541

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 103

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 101

Statement of Portfolio Changes for the financial period ended 31 December 2025 (Unaudited) (continued)

Boreas Solactive Quantum Computing UCITS ETF*Major Purchases<Security Description Nominal CostUSD

D-Wave Quantum Inc54,6981,465,168

Quantum Computing Inc57,8541,328,185

Rigetti Computing Inc41,9451,194,019

IonQ Inc15,0741,052,932

SEALSQ Corp164,725986,045

Alphabet Inc2,952775,427

Applied Digital Corp34,051697,483

International Business Machines Corp2,349656,259

Honeywell International Inc2,854580,365

NVIDIA Corp3,098552,192

SkyWater Technology Inc32,365463,410

ASP Isotopes Inc49,413443,712

Microchip Technology Inc6,947420,688

Microsoft Corp759391,582

Booz Allen Hamilton Holding Corp4,076384,644

FormFactor Inc9,549364,047

Fortinet Inc3,200272,442

Marvell Technology Inc3,563267,286

Micron Technology Inc1,474242,023

Amazon.com Inc932223,453

Intel Corp7,005207,542

Aeluma Inc11,693181,819

Onto Innovation Inc1,325163,706

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025.

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 104

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 102

Statement of Portfolio Changes for the financial period ended 31 December 2025 (Unaudited) (continued)

Boreas Solactive Quantum Computing UCITS ETF*Major Sales<Security Description Nominal ProceedUSD

D-Wave Quantum Inc31,690994,545

Applied Digital Corp29,297956,486

Rigetti Computing Inc24,168922,436

Quantum Computing Inc22,548355,219

IonQ Inc4,469274,719

Intel Corp5,231199,891

Micron Technology Inc29262,116

Alphabet Inc22053,325

NVIDIA Corp27250,977

International Business Machines Corp15644,719

Chemours Co/The3,03437,265

Microsoft Corp6433,169

QUALCOMM Inc17630,976

FormFactor Inc80030,950

Honeywell International Inc14830,530

Marvell Technology Inc33229,005

SkyWater Technology Inc1,41226,976

Skyworks Solutions Inc28721,086

Booz Allen Hamilton Holding Corp20420,605

SEALSQ Corp3,79219,074

*Boreas Solactive Quantum Computing UCITS ETF was launched on 19 September 2025.

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 105

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 103

Statement of Portfolio Changes for the financial period ended 31 December 2025 (Unaudited) (continued)

Boreas S&P AI Data, Power and Infrastructure UCITS ETF**Major Purchases<Security Description Nominal CostUSD

Alphabet Inc3,8421,223,799

Broadcom Inc2,7291,031,663

Iberdrola SA49,4161,027,932

Amazon.com Inc4,187947,633

NextEra Energy Inc11,220945,338

ABB Ltd12,808884,411

Constellation Energy Corp2,420856,935

Microsoft Corp1,797851,859

Siemens AG3,309851,084

Schneider Electric SE3,261841,242

Eaton Corp PLC2,503827,241

Equinix Inc884672,318

Oracle Corp3,267654,296

Emerson Electric Co4,767613,314

Enel SpA59,856612,139

Quanta Services Inc1,346595,895

National Grid PLC38,433564,721

Vertiv Holdings Co3,234546,336

Digital Realty Trust Inc2,897460,672

Dominion Energy Inc6,559404,166

Engie SA15,718392,898

Rockwell Automation Inc945363,249

Exelon Corp7,762358,993

Entergy Corp3,431327,661

Legrand SA2,203326,224

Public Service Enterprise Group Inc3,835315,084

E.ON SE17,050300,922

Prysmian SpA2,657254,566

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025.

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 106

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 104

Statement of Portfolio Changes for the financial period ended 31 December 2025 (Unaudited) (continued)

Boreas S&P AI Data, Power and Infrastructure UCITS ETF**Major Sales<Security Description Nominal ProceedUSD

Alphabet Inc5617,321

Iberdrola SA71115,141

ABB Ltd18513,710

Siemens AG4813,500

Schneider Electric SE4713,415

Amazon.com Inc6013,351

Broadcom Inc3913,252

NextEra Energy Inc16113,142

Constellation Energy Corp3512,499

Microsoft Corp2612,345

Eaton Corp PLC3611,995

Emerson Electric Co699,470

Equinix Inc129,136

Enel SpA8628,986

Oracle Corp478,690

National Grid PLC5538,339

Quanta Services Inc198,281

Vertiv Holdings Co467,439

Digital Realty Trust Inc426,421

Engie SA1022,609

Dominion Energy Inc432,572

Rockwell Automation Inc62,410

**Boreas S&P AI Data, Power and Infrastructure UCITS ETF was launched on 24 November 2025

< In accordance with the Central Bank UCITS Regulations, the annual report and audited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the year. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or aggregate disposals greater than 1 per cent of the total value of sales for the year. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 107

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2025 105

Appendix 1: UCITS V Remuneration Policy (Unaudited)FundRock Management Company S.A.

FundRock Management Company S.A. (“FundRock”) as subject to CSSF Circular 18/698 has implemented a remuneration policy in compliance with Articles 111a and 111b of the 2010 Law and/or Article 12 of the 2013 Law respectively.

FundRock as subject to Chapter 15 of the 2010 Law and AIFM must also comply with the guidelines of the European Securities and Markets Authority ESMA/2016/5758 and ESMA/2016/5799 to have sound processes in place. Fundrock has established and applies a remuneration policy in accordance with the ESMA Guidelines on sound remuneration policies under the UCITS V Directive (ESMA 2016/575) and AIFMD (ESMA 2016/579) and any related legal & regulatory provisions applicable in Luxembourg.

Further, consideration has been given to the requirements as outlined in Regulation (EU) 2019/2088 on sustainability – related disclosures in the financial sector, the SFDR Requirements.

The remuneration policy is aligned with the business strategy, objectives, values and interests of FundRock and the Funds that it manages and of the investors in such Funds, and which includes, inter alia, measures to avoid conflicts of interest; and it is consistent with and promotes sound and effective risk management and does not encourage risk taking which is inconsistent with the risk profiles, rules or instruments of incorporation of the Funds that the Management Company manages.

FundRock ensures that its remuneration policy adequately reflects the predominance of its oversight activity within its core activities. As such, it should be noted that FundRock’s employees who are identified as risk-takers are not remunerated based on the performance of the funds under management.

A paper version of the remuneration policy is made available free of charge to investors at FundRock’s registered office.

FundRock’s remuneration policy can also be found at: https://www.fundrock.com/policies-and-compliance/remuneration-policy/ The total amount of remuneration for the financial year ending 31 December 2025 paid by FundRock to its staff: EUR 14,377,713 (31 December 2024: EUR 9,805,298)

Fixed remuneration: EUR 13,380,075 (31 December 2024: EUR 9,486,232)Variable remuneration: EUR 997,638 (31 December 2024: EUR 319,066)Number of beneficiaries: 97 (31 December 2024: 214)

The aggregated amount of remuneration for the financial year ending 31 December 2025 paid by FundRock to Identified staff/risk takers is EUR 3,554,979 (31 December 2024: EUR 1,518,834).

The total amount of remuneration is based on a combination of the assessment of the performance of the individual, the overall results of FundRock, and when assessing individual performance, financial as well as non-financial criteria are taken into account.

The Policy is subject to annual review by the Compliance Officer and the update is performed by HR department of FundRock and is presented for review to the Remuneration Committee and approval by the Board of FundRock.

Page 108

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025106

Appendix II: Securities Financing Transactions Regulation (“SFTR”) Disclosures (Unaudited)

The ICAV is required to report in the financial statements on a semi-annual basis, certain disclosures as set out in Article 13 of the European Commission Regulation 2015/2365 on transparency of securities financing transactions and of reuse of collateral (the “Regulation”).

Neither the ICAV nor the Sub-Funds engaged in any securities financing transactions during the financial year ended 31 December 2025, as a result, there is nothing to report in that regard.

Page 109

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2025107

Appendix III: Sustainable Finance Disclosure Regulation (“SFDR”) Disclosures (Unaudited)

The investments underlying this financial product do not take into account the EU criteria for environmentally sustainable economic activities. This ICAV does not have as its objective sustainable investment, nor does it promote environmental or social characteristics. As a result, the ICAV does not fall within the scope of Regulation (EU) 2020/852 of the European Parliament and of the Council on the establishment of a framework to facilitate sustainable investment.

CHAE: Financial Statements for the period from January 2025 to December 2025